10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 10-Q/A

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2019

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period From ________ to _________

Commission File Number 000-11730

NEWBRIDGE GLOBAL VENTURES, INC.

(Exact name of registrant as specified in its charter)

Delaware	84-1089377
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
825 East 800 North
Orem, Utah	84097
(Address of principal executive offices)	(Zip Code)

801-362-2115
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes þ  Noo

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.)

Yes þ  No o

Indicate by check mark whether the registrant is a large accelerated filed, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.  

Large accelerated filer o Accelerated filer o 

Non-accelerated filer þSmaller reporting company þ 

Emerging growth company þ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)

Yes o   Noþ

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

As of June 30, 2019, the registrant had 63,098,055 shares of common stock, par value $0.0001 per share, issued and outstanding.

Explanatory Note

This Form 10-Q/A revises the Form 10-Q filed on July 11, 2019 (the “Original 10-Q”) to include the XBRL which was omitted from the Original 10-Q.

2

TABLE OF CONTENTS

	PART I - FINANCIAL INFORMATION
ITEM 1.	INTERIM FINANCIAL STATEMENTS	4
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS AND PLAN OF OPERATIONS	22
ITEM 3	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	24
ITEM 4	CONTROLS AND PROCEDURES	24
	PART II - OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS	25
ITEM 1A.	RISK FACTORS	25
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES	25
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	25
ITEM 4.	MINE SAFETY DISCLOSURES	25
ITEM 5.	OTHER INFORMATION	25
ITEM 6.	EXHIBITS	26
SIGNATURES		26

3

PART I - FINANCIAL INFORMATION

Item 1.  Interim Financial Statements

NEWBRIDGE GLOBAL VENTURES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
	March 31,	December 31,
	2019	2018
	(Unaudited)	(As Adjusted)
ASSETS
Current Assets
Cash and cash equivalents	$38,688	$89,550
Prepaid expenses and other current assets	105,587	17,421
Total current assets	144,275	106,971
Operating lease right-of-use asset	254,199	258,276
Property and equipment, net	7,724,179	5,247,309
Intangible assets, net	2,644,246	-
Goodwill	9,245,953	9,245,953
Investment in joint venture	39,912	-
Other assets	4,424	-
Total Assets	$20,057,188	$14,858,509
LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities
Accounts payable	$1,886,273	$740,660
Accrued liabilities	706,517	314,715
Related party payables	941,584	106,093
Notes payable related parties	872,169	958,467
Current portion of operating lease liability	17,362	16,935
Current portion of notes payable, net of discount	20,109	23,355
Convertible notes payable, net of discount	537,494	-
Total current liabilities	4,981,508	2,160,225
Operating lease liability, net of current portion	236,837	241,341
Notes payable, net of current portion and discount	709,781	710,972
Total Liabilities	5,928,126	3,112,538
Commitments and Contingencies	-	-
STOCKHOLDERS'  EQUITY
Preferred stock, $.0001 par value, 400,000 shares authorized; no shares issued and outstanding	-	-
Common stock $.0001 par value, 100,000,000 shares authorized; 59,698,055 and 57,116,055 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively.	5,970	5,712
Additional paid-in capital	19,679,205	15,209,596
Accumulated deficit	(5,556,113)	(3,469,337)
Total stockholders' equity	14,129,062	11,745,971
Total Liabilities and Stockholders' Equity	$20,057,188	$14,858,509
See accompanying notes to the condensed consolidated financial statements.

4

NEWBRIDGE GLOBAL VENTURES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
	For the Three Months Ended
	March 31,	March 31,
	2019	2018
Revenue:
Rental income	$-	$3,600
Consulting services	22,725	-
Total Revenue	22,725	3,600
Operating Expenses:
Selling, general and administrative	1,765,654	55,853
Total Operating Expenses	1,765,654	55,853
Loss from Operations	(1,742,929)	(52,253)
Other Expense:
Loss on investment in joint venture	(12,538)	-
Interest expense	(331,309)	(4,391)
Total Other Expense	(343,847)	(4,391)
Net Loss	$(2,086,776)	$(56,644)
Net loss per common share - basic and diluted	(0.04)	(0.01)
Weighted average common shares
outstanding - basic and diluted	58,546,944	5,173,979
See accompanying notes to the condensed consolidated financial statements.

5

NEWBRIDGE GLOBAL VENTURES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
			Additional
	Common Stock		Paid-in	Accumulated
	Shares	Amount	Capital	Deficit	Total
Balance at December 31, 2017	3,695,604	$370	$1,961,273	$(122,253)	$1,839,390
Capital contributions for stock	4,338,750	434	37,276	-	37,710
Net loss	-	-	-	(56,644)	(56,644)
Balance at March 31, 2018	8,034,354	$804	$1,998,549	$(178,897)	$1,820,456
			Additional
	Common Stock		Paid-in	Accumulated
	Shares	Amount	Capital	Deficit	Total
Balance at December 31, 2018	57,116,055	$5,712	$15,209,596	$(3,469,337)	$11,745,971
(as adjusted)
Stock issued for services	232,000	23	294,057	-	294,080
Stock issued in asset acquisition	2,350,000	235	3,031,265	-	3,031,500
Debt discount on convertible debt	-	-	1,031,040	-	1,031,040
Share-based compensation	-	-	113,247	-	113,247
Net loss	-	-	-	(2,086,776)	(2,086,776)
Balance at March 31, 2019	59,698,055	$5,970	$19,679,205	$(5,556,113)	$14,129,062
See accompanying notes to the consolidated financial statements.

6

NEWBRIDGE GLOBAL VENTURES, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
	For the Three Months Ended
	March 31,
	2019	2018
Cash Flows From Operating Activities
Net loss	$(2,086,776)	$(56,644)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	18,009	15,595
Amortization expense	176,284	-
Share-based compensation	113,247	-
Stock issued for services	294,080	-
Amortization of debt discount	239,040	-
Loss on investment in joint venture	12,538	-
Noncash lease expense	4,077
Operating expenses and interest paid through member contributions	-	34,544
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(88,166)	-
Accounts payable	27,264	-
Accrued liabilities	465,998	-
Related party payables	(75,073)	8,500
Operating lease liability	(4,077)	-
Other assets	(4,424)	-
Net Cash Provided by (Used in) Operating Activities	(907,979)	1,995
Cash Flows From Investing Activities
Purchase of property and equipment	(307,446)	-
Net Cash Used in Investing Activities	(307,446)	-
Cash Flows From Financing Activities
Proceeds from issuance of convertible notes payable	1,304,000	-
Principal payments on notes payable	(4,437)	-
Principal payments on unsecured notes payable, related parties	(135,000)	-
Net Cash Provided by Financing Activities	1,164,563	-
Net Increase (Decrease) in Cash	(50,862)	1,995
Cash at Beginning of Period	89,550	-
Cash at End of Period	$38,688	$1,995

7

Noncash Investing and Financing Information:
Long-term assets purchased through share issuance	$3,031,500	$-
Long-term assets purchased through accounts payable	$1,118,349	$-
Long-term assets purchased through related party payables	$910,564	$-
Long-term assets contributed to joint venture	$52,450	$-
Debt discount on convertible notes payable	$1,031,040	$-
Payments on notes payable through member contributions	$-	$3,166
Operating expenses paid through member contributions	$-	$34,544
See accompanying notes to the condensed consolidated financial statements.

8

NEWBRIDGE GLOBAL VENTURES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1 — THE COMPANY AND BASIS OF PRESENTATION

Financial Statement Presentation and principles of consolidation – The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America and include the operations and balances of NewBridge Global Ventures, Inc. (“NewBridge”) and its wholly-owned subsidiaries, Elevated Education, Inc. (“Elevated”), 5Leaf, LLC (“5Leaf”), Genus Management Group, LLC (“Genus”), Mad Creek Farm, LLC (“Mad Creek”), 725 E 11th, LLC (“11th Street”), Timothy Lane LLC (“Timothy”), East 10^th Street LLC (“10^th Street”), The Bay Clonery, LLC (“Bay Clonery”), Roots of Caly, LLC (“Roots”), and 50% owned subsidiary Green Thumb Distributors, Inc. (“Green Thumb”). The consolidated financial statements include the operations of NewBridge and Elevated since July 14, 2018 which operations are continuing (see Reverse Acquisition below).  Genus, Timothy, 10^th Street, Green Thumb, Bay Clonery, and Roots were formed in 2018 (collectively, “New Entities”, “we”, or “the Company”).  Intercompany balances and transactions have been eliminated in consolidation.

Organization – On July 14, 2018, NewBridge closed on Share Exchange and Purchase Agreements (the “Purchase Agreements”, the “July Acquisitions”, the “Closing”) with the various members and shareholders of 11^th Street, Mad Creek, Timothy, Genus (formerly GLML) and 5Leaf (together the “Consortium”), whereby NewBridge purchased the shares or membership interests of the several entities making up the Consortium for a combined 31,000,000 shares of the Company’s common stock, par value $0.0001 per share. The Consortium consists of a farm, nursery, extraction facility, and management and real estate companies in the cannabis industry.  

Reverse Acquisition – The 31,000,000 shares issued to the Consortium represented 76% of the 40,904,589 shares of the Company’s common stock issued and outstanding immediately following the July Acquisitions. In addition, three of the four board members were replaced by the sellers at the Close. Due to the relative size of the Consortium compared to the Company prior to the Closing and the change in control of the Company, the July Acquisitions were considered a reverse acquisition and the Consortium is the acquirer for accounting purposes.  The historical financial statements are of the Consortium.

Nature of Business – The Company is vertically integrated and through its subsidiaries intends to cultivate, manufacture, and distribute industrial hemp throughout the United States and medical and recreational cannabis in California as follows:

Mad Creek Farm—plans to be a grower of cannabis, 

5Leaf—plans to manufacture and extract oils from hemp and cannabis, 

Green Thumb—has applied for a California Type 11 license in the Bay area, 

Genus—plans to provide consulting services to cultivators, processors and retailers.  

Elevated Education—is creating and plans to market curriculum focused on the endocannabinoid system, pharmacology and clinical applications of medical cannabis. 

Bay Clonery—plans to operate as an indoor nursery and tissue culture lab and to cultivate and market cannabis clones. 

10^th Street, 11^th Street, and Timothy Lane—will operate as real estate holding companies. 

Roots of Caly—plans to operate as an indoor nursery and to cultivate and market cannabis clones. 

9

NOTE 2 – GOING CONCERN

The accompanying condensed consolidated financial statements have been prepared with the recognition that there is considerable doubt about whether the Company can continue as a going concern.  As shown in the accompanying condensed consolidated financial statements, the Company incurred a net loss of $2,086,776 for the three months ended March 31, 2019 and has an accumulated deficit of $5,556,113 at March 31, 2019.  The Company also used cash in operating activities of $907,979 during the three months ended March 31, 2019.   The Company is also in default on its notes payable related party and has construction liens on some of its property.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Information – The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the SEC.  Accordingly, they are condensed and do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements.  In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal recurring nature.  The results of operations for the three months ended March 31, 2019, may not be indicative of the results that may be expected for the year ending December 31, 2019.

These financial statements should be read in conjunction with the financial statements and notes thereto which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.

Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  

Fair Value – The fair values of the Company’s financial assets and liabilities approximate their carrying amounts at the reporting date.

Cash and Cash Equivalents – The balance in cash and cash equivalents consists of cash reserves held in bank accounts. The Company maintains cash balances in bank accounts that, at times, exceed federally insured limits.  The Company has not experienced any losses in these accounts and believes it is not exposed to any significant risk with respect to cash.

Property and Equipment – Property and equipment are stated at cost.  Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets.  Expenditures that materially increase values or capacities or extend useful lives of property and equipment are capitalized.  Leasehold improvements are assigned useful lives based on the shorter of their useful lives or the term of the related leases, including renewal options likely to be exercised.  Routine maintenance, repairs and renewal costs are expensed as incurred.  When property is retired or otherwise disposed of, the carrying values are removed from the property and equipment and related accumulated depreciation and amortization accounts.  

Goodwill – The Company tests its recorded goodwill for impairment annually on November 30, or more often if indicators of potential impairment exist, by determining if the carrying value of each reporting unit

10

exceeds its estimated fair value. Factors that could trigger impairment include, but are not limited to, underperformance relative to historical or projected future operating results, significant changes in the manner of use of the acquired assets or the Company’s overall business and significant negative industry or economic trends. Future impairment reviews may require write-downs in the Company’s goodwill and could have a material adverse impact on the Company’s operating results for the periods in which such write-downs occur.  As of March 31, 2019 and 2018, goodwill was $9,245,953 and $0, respectively.

Long-Lived Assets – Long-lived assets are reviewed for impairment when events or changes in circumstances indicate the carrying values of the assets may not be fully recoverable. When this occurs, the Company reviews the values assigned to long-lived assets by analyzing the anticipated, undiscounted cash flows they generate.  When the expected future undiscounted cash flows from these assets do not exceed their carrying values, the Company estimates the fair values of such assets. Impairment is recognized to the extent the carrying values of the assets exceed their estimated fair values.  Assets held for sale are reported at the lower of their carrying values or fair values less costs to sell.

Research and Development – Research and development costs are expensed as incurred and are included in selling, general and administrative expense.

Stock-Based Compensation – The Company records compensation expense in the financial statements for stock-based awards based on the grant date fair value of those awards that are ultimately expected to vest. As such, the value of the award is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company determines the grant date fair value of the options using the Black-Scholes option-pricing model.  Stock-based compensation expense is recognized over the requisite service periods of the awards on a ratable basis, which recognizes expense for each vesting tranche of each grant starting on the grant date and finishing on the vest date for that tranche.

Revenue Recognition – The Company generates revenue through consulting arrangements, and in the future from manufacturing services, producing and selling products.  The revenue will be recognized at the point in time that the services are performed and products are sold and delivered to the customer.  This policy will be modified if necessary as the Company grows and develops multiple revenue sources. The company had rental income prior to the recent quarter.  The rental income was recognized monthly when earned and collection reasonably assured.  

Income Taxes – The Company accounts for income taxes pursuant to Accounting Standards Codification (ASC) 740, Income Taxes, which requires the use of the asset and liability method of accounting for deferred income taxes.  We recognize deferred tax liabilities and assets based on the differences between the tax basis of assets and liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years.

All allowances against deferred income tax assets are recorded in whole or in part, when it is more likely than not those deferred income tax assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

A valuation allowance is required to the extent it is more-likely-than-not that a deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits.

Basic and Diluted Loss Per Share – Basic loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is

11

calculated by dividing net loss by the weighted-average number of common shares outstanding during the period giving effect to potentially dilutive common stock equivalents.  As of March 31, 2019 and 2018, the Company had 4,834,000 and 0, respectively, common stock equivalents outstanding.    

Customer Concentration – Concentration of credit risk with respect to accounts receivable is limited due to only having a few sales. For consulting revenue, the Company had one customer account for 100% of total rental income for the three months ended March 31, 2019.  There was no consulting revenue during the three months ended March 31, 2018.   For rent revenue, the Company had one tenant account for 100% of total rent revenue for the three months ended March 31, 2018.  There was no rent revenue for the three months ended March 31, 2019.

Recent Accounting Pronouncements – In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 changes the accounting for leases. In particular, lessees will recognize lease assets and lease liabilities for operating leases. The Company adopted ASU 2016-02 on January 1, 2019 as described in Note 11.

NOTE 4 – CHANGES IN ACCOUNTING PRINCIPLE

As described in Note 6, the Company adopted Topic 842 Leases, effective January 1, 2019 resulting in the retrospective adjustment of the comparative 2018 periods presented. Prior to the application of Topic 842, the rent expense was recorded in the amount of the lease payments, adjusted on straight-line basis over the lease term. The presented condensed consolidated statement of operations and condensed consolidated statement of cash flows for the three-month period ended March 31, 2018 were not adjusted since the lease did not commence until August 1, 2018. The balance sheet presented as of December 31, 2018 is adjusted to reflect the ROU asset and operating lease liability described in Note 6.  Stockholders’ equity was not affected since the total 2018 expense remained the same.

NOTE 5 – ASSET PURCHASE AGREEMENT AND JOINT VENTURE

On February 14, 2019, the Company and EcoXtraction LLC, a Louisiana limited liability company (the “Seller”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company issued to the Seller an aggregate of 2,350,000 shares of the Company’s common stock par value $0.0001 per share (the “Shares”) and the Seller sold to the Company certain equipment and other tangible property. In connection with the Purchase Agreement, the Company and the Seller entered into a Lock-Up Agreement, which provides that, among other things, the Seller may not liquidate any of the Shares received in connection with the Purchase Agreement until September 30, 2020 (the “Lock-Up Agreement”). Further, in connection with the Purchase Agreement and the Lock-Up Agreement, the Company and the Seller entered into a Registration Rights Agreement, wherein the Company agreed to provide certain registration rights under the Securities Act of 1933 (the “Securities Act”) including an obligation to, within ninety (90) days following the Seller’s written request, prepare and file with the Securities and Exchange Commission (the “SEC” or the “Commission”) a Registration Statement or Registration Statements on Form S-1, or such other applicable form if Form S-1 is not available.  

The purchase accounting consisted of the following:

Machinery and equipment	$210,970
Technology licensing rights	2,820,530
Total assets	$3,031,500

The above table is a provisional valuation.  A formal valuation will be obtained for the year end financial statements.

The 2,350,000 shares issued on February 14, 2019 were valued at $1.29 per share, $3,031,500 in total.

12

The Purchase Agreement conveyed only assets; the Company did not receive any ownership interest in or to the Seller or the securities of the Seller and the Company does not consider it to be an acquisition of a business. The Company and the Seller also took steps described herein to create a joint venture (the “Joint Venture”).  

In connection with the Purchase Agreement, on February 14, 2019, the Company and the Seller entered into a License Agreement, pursuant to which Seller sub-licensed to the Company certain intellectual property relating to cannabis extraction technology which the Seller licenses from Hydro Dynamics, Inc. (“Hydro”) (the “License Agreement”). Subject to the terms of the License Agreement, the Seller grants to the Company certain licenses, including an exclusive license for an initial term of two (2) years from the effective date of the agreement (the “Exclusive License”). The Company has the option to renew the Exclusive License for two (2) successive additional terms of one (1) year each. The Company shall exercise its renewal option by giving the Seller written notice of the Company’s intent to renew the license; in consideration for each one-year renewal term, the Company shall issue to the Seller 250,000 shares of the Company’s common stock. The Company is under no obligation to renew.  

On February 14, 2019, the Company, EcoX and CleanWave entered into an Assignment and License Agreement (the “A&L Agreement”), pursuant to which the Seller agreed to assign and/or license certain intellectual property to CleanWave, and the Company agreed to contribute an aggregate of $2,000,000 of cash contributions to CleanWave (the “Cash Contribution”) such Cash Contribution being made no later than by the second anniversary of the effective date of the A&L Agreement. If the Cash Contribution is not met, then ownership of certain intellectual property described in the A&L Agreement shall revert back to EcoX, and CleanWave would execute all documents necessary to re-assign such intellectual property back to EcoX.

In connection with the Purchase Agreement, on February 15, 2019, the Company and EcoX created CleanWave Labs, LLC, a Nevada limited liability company (“CleanWave”) with each of the Company and EcoX as the members of CleanWave (the “Operating Agreement”). The Company shall own 50% of the member equity interests and 50% of the member profit interests of CleanWave. CleanWave was formed primarily for the purpose of (i) developing and exploiting certain proprietary technologies being assigned and licensed to the Company by EcoX designed to extract CBD, THC, as well as additional compounds from cannabis and hemp plants and (ii) manufacture and market equipment derived from that technology for use in extracting CBD, THC and additional compounds.  Pursuant to the terms of the Operating Agreement and in consideration of its membership interests, the Company shall provide certain equipment, as well as $2,000,000 in working capital over a two-year period, with the first $150,000 of the $2,000,000 paid to Hydro upon election to be used to pay Hydro the amount owed by EcoX to Hydro. The Company has not yet made the $150,000 payment to Hydro.

As of March 31, 2019, the Investment in CleanWave was $39,912, which consisted of $52,450 of equipment contributed from NewBridge to CleanWave, less $12,537 for NewBridge’s share of the net loss of CleanWave during the three months ended March 31, 2019.

The Company analyzed CleanWave and determined that it is a variable interest entity since the total equity investment is not sufficient to permit the entity to finance its activities without additional funding from NewBridge.  Also, neither NewBridge nor EcoX have a controlling financial interest in CleanWave since neither entity has the power to direct the activities of CleanWave that most significantly impact the economic performance of CleanWave.  This is because neither party can approve the annual budget without the other party’s agreement since neither party has a majority interest.  As a result, neither party is the primary beneficiary.  NewBridge accounted for its interest in CleanWave using the equity method.

13

NOTE 6 – OPERATING LEASES

The Company adopted Topic 842, Leases, effective January 1, 2019 and adjusted the 2018 comparative period presented by applying the new standard as of January 1, 2018. As a result, the 2018 periods presented for comparative purpose have been adjusted to reflect the application of Topic 842 with an adjustment to opening balance of stockholders’ equity at January 1, 2018 for cumulative effect of the initial application (see Note 4).

The Company leases a 4,200 square foot facility in Oakland, California for $3,500 per month. After year one, the Landlord can increase the rent to fair market value, not to exceed $3.50 per square foot.  The lease commenced August 1, 2018 and expires August 1, 2028.  The lessor is Hong So Mac, a related party.  Although possible, the Company does not anticipate an increase in the rent.    

As a result of the adoption of ASC 842, the Company recognized an operating liability with a corresponding right-of-use (“ROU”) asset of the same amount based on the present value of the minimum rental payments of the lease as of August 1, 2018.   The discount rate used to compute the present value of the minimum rental payments of the lease is the Company’s estimated borrowing rate of 10%.  The ROU asset is amortized on a straight-line basis over the remaining term of the lease, which is recorded as rent expense.

Balance sheet information related to the lease is as follows:

	March 31,		December 31,
	2019		2018
Operating lease right-of-use asset	$	254,199		258,276
Operating lease liability, current portion		(17,362)		(16,935)
Operating lease liability, net of current portion		(236,837)		(241,341)

The components of lease expense are as follows:

	March 31,		March 31,
	2019		2018
Amortization of right-of-use asset recorded as rent expense	$	4,077	$	-
Interest on lease liability included in other expense		6,423		-
Total lease cost	$	10,500	$	-

Maturities of the lease liability are as follows:

Future Minimum Lease Payments
2019	$	42,000
2020		42,000
2021		42,000
2022		42,000
2023		42,000
Thereafter		210,000
Total future minimum lease payments	$	420,000
Less: amount representing interest		(165,801)
Present value of future payments	$	254,199
Current portion		17,362
Long-term portion		236,837

14

Other information related to the lease:

	March 31,		March 31,
	2019		2018
Operating cash flows
Cash paid related to operating lease obligations	$	10,500		-
Weighted average remaining lease term (in years)
Operating leases		9.33		-
Weighted average discount rate
Operating leases		10.0%		0.0%

On March 31, 2019, there was a fire on the property next to the location the lease making the building uninhabitable since then.  The city removed the red tag on the property on June 17 so now the landlord can get the insurance company to assess the water damage and begin repairing the building.  It will likely continue to be uninhabitable through September 2019. According to the lease, the Company does not have to make lease payments while the building is uninhabitable and also has the option to terminate the lease if it chooses.  The Company has not made a decision yet on whether to terminate the lease and stopped paying rent until the property is fixed.  The ROU asset and lease liability will continue to decrease as originally scheduled.

NOTE 7 – PROPERTY AND EQUIPMENT

As of March 31, 2019, the Company’s property and equipment consists of the following:

Property and equipment consisted of the following:
	Estimated	March 31,	December 31,
	Useful Lives	2019	2018
Land	n/a	$908,271	$908,271
Buildings and improvements	5-30 years	2,391,922	2,391,922
Machinery and equipment	3-8 years	893,562	424,461
Office furniture and equipment	3-8 years	26,120	23,146
Construction in progress	n/a	3,734,847	1,712,043
Total		7,954,722	5,459,843
Less accumulated depreciation		(230,543)	(212,534)
Net property and equipment		$7,724,179	$5,247,309

For the three months ended March 31, 2019 and 2018, the Company had depreciation expense of $18,009 and $15,595, respectively.

15

NOTE 8 – INTANGIBLE ASSETS

As of March 31, 2019, the intangible assets consist of the following:

	Estimated	March 31,
	Useful Life	2019
Technology licensing rights	2 years	$ 2,820,530
Total		2,820,530
Less accumulated amortization		(176,284)
Net intangible assets		$ 2,644,246

The technology licensing rights were acquired as part of the asset purchase agreement (see Note 5).  The Company has an exclusive license to water extraction technology for two years and a non-exclusive license in perpetuity.  For the three months ended March 31, 2019, the Company had amortization expense of $176,284.

16

NOTE 9 – CONVERTIBLE NOTES PAYABLE

On January 7, 2019, the Company completed the first close on a $7.5 million private offering of securities (the “Offering”), whereby the Company entered into a Note Purchase Agreement (the “Purchase Agreement”) with certain accredited investors, pursuant to which the Company issued to those investors $1,074,000 worth of 10% convertible promissory notes, convertible into shares of the Company’s common stock, par value $0.0001 per share at a  conversion price of $1.00 per share upon the terms and subject to the conditions set forth in the Note Purchase Agreement and the Notes (the “Notes”), for a maximum of $7.5 million. The Notes have a maturity date of December 31, 2019 if not converted.  The Company recorded a beneficial conversion feature of $1,031,040 upon issuance and recognized amortization of the debt discount of $239,040 for the three months ended March 31, 2019. On March 14, 2019, the Company completed the second close and issued $230,000 worth of 10% convertible promissory notes.  The terms and maturity date are the same as those for the January 7 closing.

The convertible notes payable consists of the following:

	March 31,	December 31,
	2019	2018
Convertible notes payable	$1,329,494	$-
Less debt discount	(792,000)	-
Convertible notes payable, net of discount	537,494	-
Less current portion	(537,494)	-
Convertible notes payable, net of current portion and discount	$-	$-

NOTE 10 – NOTES PAYABLE

As of March 31, 2019, the Company’s notes payable consisted of bank loans of $346,041 on the Mad Creek property and $383,848 on the 10^th Street property, which was assumed when the property was deeded to the Company on September 12, 2018.  The Mad Creek loan had a variable interest rate of 4.75% as of March 31, 2019 that adjusts on May 1 and November 1 each year.  The loan matures on November 1, 2036.  The 10^th Street loan has a fixed interest rate of 9.66% and a maturity date of July 1, 2036.  

	March 31,	December 31,
	2019	2018
Note payable	$729,890	$734,327
Less current portion	(20,109)	(23,355)
Note payable, net of current portion	$709,781	$710,972

17

NOTE 11 – STOCK OPTIONS

As of March 31, 2019, options to purchase 3,380,000 shares of common stock under the Company’s stock option plan were authorized and reserved for future grant.  A summary of activity in the stock option plan for the three months ended March 31, 2019 is as follows:

	2019
		Weighted-
		Average
	Number	Exercise
	of Shares	Price
Outstanding as of beginning of the period	1,580,000	$0.25
Granted	1,950,000	0.89
Exercised	-	-
Forfeited or expired	-	-
Outstanding as of end of the period	3,530,000	0.60
Exercisable as of end of the period	3,530,000	0.60

As of March 31, 2019, options exercisable and options outstanding had a weighted average remaining contractual term of 3.04 years and had an aggregate intrinsic value of $584,216.

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for the grants made in the three months ended March 31, 2019:

	2019
Expected life (in years)	3.04
Risk free rate	2.9%
Volatility	459.7%
Dividend yield	-

Expected option life and volatility are based on historical data of the Company.   The risk-free interest rate is calculated based on the average US Treasury bill rate that corresponds with the option life.  Historically, the Company has not declared dividends and there are no foreseeable plans to do so.

As of March 31, 2019, there was $2,815,924 of unrecognized share-based compensation cost related to grants under the stock option plans that will be recognized over a weighted-average period of 3 years.

Share-based compensation expense included in selling, general and administrative expense in the statements of income for each of the three-month periods ended March 31, 2019 and 2018 was $113,247 and $0, respectively.

18

NOTE 12 – SHAREHOLDERS’ EQUITY

We have authorized capital stock consisting of 100,000,000 shares of $0.0001 par value common stock and 400,000 shares of $0.0001 par value preferred stock. At March 31, 2019 and December 31, 2018, we had 59,698,055 and 57,116,055 shares of common stock issued and outstanding, respectively, and no shares of preferred stock issued and outstanding.

During January 2019, the Company issued 32,000 shares to Patrick Tang for compensation through March 31, 2019 and issued 200,000 shares to John MacKay as a signing bonus.  The Company recognized share-based compensation of $46,080 and $248,000, respectively, related to these issuances.  The value was based on the fair value of the Company’s common stock.

On February 14, 2019, the Company issued 2,350,000 shares to EcoXtraction LLC for the asset acquisition as described in Note 5.  The shares were valued at $1.29 per share for a total valuation of $3,031,500. The value was based on the fair value of the Company’s common stock.

NOTE 13 – COMMITMENTS AND CONTINGENCIES

As discussed in Note 5, the Company is committed to contributing $2,000,000 to CleanWave by February 14, 2021 to fund the joint venture’s operations.  

NOTE 14 – RELATED PARTY TRANSACTIONS

The Company is leasing 4200 square feet of property from Hong So Mac, the father of Sam Mac, one of the principal shareholders (see Note 6).  Total rent payments of $10,500 were made for the three months ended March 31, 2019.  

On December 31, 2018, the Company issued notes payable of $958,467 to several of its principal shareholders, members of management and affiliated companies.  The notes have been classified as notes payable related party.  The notes bear interest at 8% and carry either a $5,000 or $1,000 late fee if not paid in full by March 31, 2019, the maturity date.  A few of the notes had due dates on March 28, 2019.  The interest increases to 12% for unpaid balances after the maturity date.  The notes are unsecured except for one note for $261,650 which is secured by equipment that was purchased with the funds from the note. Most of the remaining balance is payable to Tran Millenium, a company owned by Eric Tran, for consulting related to the formation, strategy, permitting, licensing, compliance and construction design for the new entities formed during 2018.  As of March 31, 2019, the Company had paid back $135,000 of the notes payable related party but was in default on the rest.  As of March 31, 2019, the Company had notes payable related parties of $872,169, which includes interest and penalties of $48,703.

As of March 31, 2019 and December 31, 2018, the Company had related party payables of $941,584 and $106,093, respectively, for reimbursable expenses.

NOTE 15 – MANAGEMENT CHANGES

On January 17, 2019, the Company announced the expansion of its corporate management team with the appointments of Dr. John MacKay as Chief Technology Officer (“CTO”), Patrick P. Tang as Chief Compliance Officer (“CCO”) and Sandra Ribble as Corporate Controller of Newbridge Global Ventures.  

19

Dr. John MacKay’s employment agreement commenced January 2, 2019 and terminates on December 31, 2021, with extensions upon mutual agreement.  His base salary is $10,000 per month and he will be issued 200,000 shares of the Company’s Common Stock par value $0.0001 as a signing bonus and he will be eligible for an annual bonus.

Patrick Tang’s employment agreement commences March 1, 2019 and terminating on December 31, 2020, with extensions upon mutual agreement.  His base salary is $10,000 per month for March thru December 2019 and then $15,000 per month for the twelve months ended December 2020.  Patrick will also be granted options to acquire 300,000 shares of the Company’s Common Stock par value $0.0001 and will be eligible for an annual bonus.  Also, on December 18, 2018, the Company signed an interim services agreement with Patrick Tang in which he received 32,000 shares of common stock for interim services from December 18, 2018 through March 2019.

On January 18, 2019, the Company granted non-statutory stock options of 1,000,000 to Synergistic Technologies Associates, LLC (a company owned by Dr. John MacKay) and 300,000 to Patrick Tang.  The options have an exercise price of $1.00 per share.

On January 17, 2019, the Board approved the 2019 Equity Incentive Plan (“2019 Incentive Plan”) in order to attract and retain qualified personnel, directors and consultants and align their interests with those of the Company’s stockholders.  The 2019 Incentive Plan reserves 5,000,000 shares of the Company’s common stock, par value $0.000l for future issuance.  The option exercise price will be set by a committee but will not be less than the fair market value of the common stock at the time of the grant.

On January 17, 2019, the Board approved the appointment of Ellen Gee as President of 5Leaf, LLC, replacing Dr. John MacKay.

On April 16, 2019, the Board appointed Arthur Kwan to the Company’s Board effective immediately.

On May 10, 2019, the Board appointed Eric Baum to the Company’s Board effective immediately.

On June 6, 2019, the Company terminated Eric Tran from his position as Chief Strategy Officer of NewBridge Global Ventures, Inc. and from his employment and directorship positions with each of the Company’s subsidiaries. Mr. Tran will remain a Director of the Company. 

NOTE 16 – SUBSEQUENT EVENTS

On April 9, 2016, effective as of April 16, 2019, the Company entered into a consulting agreement with Aston Capital where it agreed to issue to Mr. Kwan an aggregate of 250,000 shares of the Company’s common stock, par value $0.0001 and granted to Mr. Kwan options to purchase an aggregate of 250,000 shares of common stock of the Company at a strike price of $0.65 per share.

On April 12, 2019, the Company and Hydro Dynamics, Inc., a Georgia corporation (“Hydro”) entered into a technology license agreement (the “Agreement”), whereby the Company would license from Hydro certain Hydro-owned technology and associated intellectual property including the ShockWave Power Reactor/Extractor, such intellectual property being useful in a variety of industries including but not limited to those industries which extract, mix, heat, hydrate, homogenize and crystallize materials (the “Hydro Technology”). Pursuant to the terms and subject to the conditions set forth in the Agreement, the Company shall, in consideration for licensing the Hydro Technology from Hydro, furnish to Hydro: (i) a one-time lump-sum cash payment of $60,000 (the “Cash Payment”) no later than July 3, 2019; (ii) four semiannual payments of $125,000 each for an aggregate of $500,000 in payments beginning on January 15, 2020 and culminating with a final payment on July 15, 2021, such $500,000 is convertible into shares of the Company’s common stock, par value $0.0001 per share at a conversion price of $1.00 per share or the market price at the time of conversion but not less than $0.75 per share; (iii) 2,125,000 shares of the Company’s

20

Common Stock (the “Stock Payment”) and (iv) an annual license fee of $100,000 no later than January 15 of each year of the Term beginning in 2022. In addition to these fees, Hydro and the Company agreed to enter into a revenue-sharing plan whereby the Company will furnish to Hydro 3% of net revenues from the Company derived by the Company’s sale or lease of certain technologies (the “Revenue-Sharing Arrangement”) and Hydro is further permitted to sell certain stand-alone products to third-parties in exchange for paying to the Company a participation fee for any such third-party sales. The agreement is perpetual, subject to the Company’s right to terminate the agreement at the end of the Company’s 2025 fiscal year. 

On April 17, 2019, the Company and King Hemp Farm NM, LLC, a New Mexico limited liability company (“King”), entered into an operating agreement (the “Operating Agreement”), pursuant to which the Companies formed King Hemp Farm LLC, a Nevada limited liability company (the “Joint Venture”). The Companies formed the Joint Venture primarily for the purpose of exploiting certain farming operations to raise hemp on properties controlled by King and to extract CBD and additional compounds from hemp plants. In connection with the Operating Agreement, King granted the Company two 10-year leases on at least 10 acres of land controlled by King. The managers of the Joint Venture are initially Robert Bench, the Company’s interim Chief Executive Officer, and Tyler King. The members of the Joint Venture are the Company and King, each with a 50% membership interest, with payment from the proceeds generated by the Joint Venture to be distributed in accord with the respective capital contributions of each of the Company and King.  King agreed to cultivate 50 acres of land in 2019 and the Company issued 1,000,000 shares, valued at $0.50 per share to King during April 2019.  

On May 1, 2019, the Company and Innovative Separations, LLC, an Oregon limited liability company (“Innovative”) together with Joseph Mazza, the managing member of Innovative (“Mr. Mazza”) entered into a letter of intent, pursuant to which the Company and Innovative will be joint partners for the purpose of exploiting certain farming operations that raise cannabis and hemp and to extract CBD, THC and other compounds from cannabis and hemp plants through the use of certain technologies and equipment (the “Innovative Transaction”). Pursuant to the terms of the letter of intent and subject to the conditions to be set forth in an Operating Agreement, the Company may: (i) issue 25,000 shares of the Company’s common stock to Mr. Mazza, and 25,000 shares of the Company’s common stock to the Gary and Gail Harstein Family Trust; (ii) enter into a lease purchase option to purchase certain property listed in the Operating Agreement; (iii) place at least one Company ShockWave Power™ Reactor in Innovative and (iv) provide cash for working capital of up to $200,000 over a one-year period. In addition to the Innovative joint venture, the Company will receive the right to use certain trade names and access to certain lands currently owned by Innovative (together with the Innovative joint venture, the “Innovative Interests”). The term proposed Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement. The Operating Agreement may also provides for certain drag-along provisions, whereby the Managers may require any members of Innovative to sell their respective Innovative MIs to a proposed purchaser.  

On May 2, 2019, the Company and Apothio, LLC, a Colorado limited liability company (“Apothio”) entered into an operating agreement (the “Operating Agreement”), pursuant to which the Company and Apothio agreed to form Apothio Bakersfield, LLC, a Nevada limited liability company (the “Joint Venture”), whereby pursuant to the terms and subject to the conditions set forth in the Operating Agreement, the Company and Apothio shall each receive fifty percent (50%) of the membership interests in the Joint Venture. Under the terms of the Operating Agreement, the Company will be required to: (i) underwrite costs to contribute extraction equipment; (ii) fund the cost of a fully-functional extraction facility and (iii) install a fully-functional testing laboratory with certain equipment as determined by the managers of the Joint Venture. Apothio will contribute existing biomass of approximately 150,000 pounds for the Company to begin processing and extraction, and will contribute some of its 512 acres of plants. The term of the Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement.  The Operating Agreement also provides for certain drag-along provisions, whereby the managers may require any members of the Joint Venture to sell their respective membership interests to a proposed purchaser.  

21

Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion is intended to assist you in understanding our results of operations and our present financial condition.  Our condensed financial statements and the accompanying notes included in this quarterly report on Form 10-Q contain additional information that should be referred to when reviewing this material.

Forward-Looking Information and Cautionary Statements

This quarterly report contains forward-looking statements as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.  These statements relate to future events or our future financial performance.  In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology.  Such statements are based on currently available financial and competitive information and are subject to various risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations.  Undue reliance should not be placed on such forward-looking statements as such statements speak only as of the date on which they are made.  These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  Such factors include, but are not limited to, market factors, market prices and marketing activity, future revenues and costs, unsettled political conditions, civil unrest and governmental actions, foreign currency fluctuations, and environmental and labor laws and other factors detailed herein and in our other filings with the U.S. Securities and Exchange Commission (the “Commission”) filings.    Additional factors that may cause actual results, our performance or achievements, or industry results, to differ materially from those contemplated by such forward-looking statements include without limitation:

·our ability to raise capital when needed and on acceptable terms and conditions; 

·our ability to identify and acquire a viable operating business; 

·our ability to attract and retain management, and to integrate and maintain technical information and management information systems; 

·the intensity of competition; and 

·general economic conditions. 

Forward-looking statements are predictions and not guarantees of future performance or events.  Forward-looking statements are based on current industry, financial and economic information, which we have assessed but which by its nature, is dynamic and subject to rapid and possibly abrupt changes.  Our actual results could differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business.  We hereby qualify all our forward-looking statements by these cautionary statements. These forward-looking statements speak only as of their dates and should not be unduly relied upon.  We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise (other than pursuant to reporting obligations imposed on registrants pursuant to the Securities Exchange Act of 1934)  to reflect subsequent events or circumstances. All written and oral forward-looking statements made in connection with this quarterly report on Form 10-Q that are attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.

Executive Summary

With a series of acquisitions and joint venture partnerships completed since January of 2019, the Company is

22

positioning itself to begin operations and growth. The Company’s recent licensing of the ShockWave Power™ Reactor (SPR), has brought us an innovative and efficient way of extracting oil from cannabis and industrial hemp at scale. The promise of this oil extraction process has led to the signing of three joint venture partnerships with hemp farms in Oregon, California, and New Mexico. This will allow the Company to expand its operations and become a player in the large and growing oil extraction niche along with our existing facilities in Oakland that are nearing completion for cloning, extraction, and distribution. We should be in operations during the quarter ending September 30, 2019 in many of our locations.

Critical Accounting Policies and Estimates

Certain accounting policies are considered by management to be critical to an understanding of our condensed consolidated financial statements.  Their application requires significant management judgment, with financial reporting results relying on estimates about the effect of matters that are inherently uncertain.  A summary of critical accounting policies can be found in our Form 10-K for the year ended December 31, 2018.  For all of these policies, management cautions that future results rarely develop exactly as forecasted, and the best estimates routinely require modification.  

Results of Operations

During the three months ended March 31, 2019, the Company had a net loss of $2,086,776 compared to a net loss of $56,644 for the three months ended March 31, 2018.  The increase in net loss was mainly due to the additional entities acquired or formed over the past year.  Operating expenses consist mainly of employee salaries, share-based compensation, consulting, legal and accounting.  We expect operating expenses to increase in the future based on the recent acquisitions and joint ventures and beginning operations.

Liquidity and Capital Resources

During the three months ended March 31, 2019, we had a net loss of $2,086,776. At March 31, 2019, we had an accumulated deficit of $5,556,113.

We could potentially use our available financial resources sooner than we currently expect, and we may incur additional indebtedness to meet future financing needs. Adequate additional funding may not be available to us on acceptable terms or at all. Additional equity financing may result in dilution to our shareholders. Our failure to raise capital as and when needed could have significant negative consequences for our business, financial condition and results of operations. Our future capital requirements and the adequacy of available funds will depend on many factors, including those set forth in the section titled “Risk Factors” noted in the filed 10-K for the year ended December 31, 2018.

The following table summarizes our cash flows for the three months ended March 31, 2019 and 2018:

Summarized Cash Flows for 10-Q/10-K
	For the Three Months Ended
	March 31,
	2019	2018
Cash provided by (used in) operating activities	$(907,979)	$1,995
Cash used in investing activities	(307,446)	-
Cash provided by financing activities	1,164,563	-
Net increase (decrease) in cash	$(50,862)	$1,995

23

Number of Employees

As of March 31, 2019, the Company had 12 full-time and 2 part-time employees.

Disclosure of Contractual Obligations

None.

Off-Balance Sheet Financing Arrangements

The Company had no off-balance sheet financing arrangements at March 31, 2019 and December 31, 2018.

Critical Accounting Policies

The Company’s Financial Statements are prepared in accordance with U.S. generally accepted accounting principles, which require management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, net revenue, if any, and expenses, and the disclosure of contingent assets and liabilities. Management bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Senior management has discussed the development, selection and disclosure of these estimates with the Board of Directors. Management believes that the accounting estimates employed and the resulting balances are reasonable; however, actual results may differ from these estimates under different assumptions or conditions. An accounting policy is deemed to be critical if it requires an accounting estimate to be made based on assumptions about matters that are highly uncertain at the time the estimate is made, if different estimates reasonably could have been used, or if changes in the estimate that are reasonably possible could materially impact the financial statements. Management believes the following critical accounting policies reflect the significant estimates and assumptions used in the preparation of the Financial Statements.

New Accounting Pronouncements

The Company does not expect the adoption of any recent accounting pronouncements to have a material impact on its financial statements.

Item 3. Qualitative and Quantitative Disclosures About Market Risk

As a Smaller Reporting Company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our President, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act.”)) and based upon this evaluation concluded that as of March 31, 2019, our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms and (ii) accumulated and communicated to our management,

24

including our principal executive and financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

None.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

There are no legal proceedings which are pending or have been threatened against us or any of our officers, directors or control persons of which management is aware.

Item 1A. Risk Factors

As a Smaller Reporting Company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On February 14, 2019, the Company issued 2,350,000 shares of restricted common stock to EcoXtraction at $1.29 per share for total consideration of $3,031,500.  

In connection with the foregoing issuances, the Company relied upon the exemption from securities registration provided by Section 4(a)(2) under the Securities Act for transactions not involving a public offering.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

25

Item 6.  Exhibits

Exhibits.  The following exhibits are included as part of this report:

EXHIBIT NO    DESCRIPTION AND METHOD OF FILING

10.1	Form of Note (incorporated by reference as Exhibit 10.1 to Form 8-K filed on January 15, 2019)
10.2	Form of Note Purchase Agreement (incorporated by reference as Exhibit 10.2 to Form 8-K filed on January 15, 2019)
10.3	Employment Agreement with Dr. John MacKay (incorporated by reference as Exhibit 10.1 to Form 8-K filed on January 18, 2019)
10.4	Employment Agreement with Patrick T. Tang (incorporated by reference as Exhibit 10.2 to Form 8-K filed on January 18, 2019)
10.5	Asset Purchase Agreement with EcoXtraction LLC (incorporated by reference as Exhibit 10.1 to Form 8-K filed on February 21, 2019)
10.6	License Agreement with EcoXtraction LLC (incorporated by reference as Exhibit 10.2 to Form 8-K filed on February 21, 2019)
10.7	Operating Agreement of CleanWave Labs, LLC (incorporated by reference as Exhibit 10.3 to Form 8-K filed on February 21, 2019)
10.8	Assignment and License Agreement with EcoXtraction LLC and CleanWave Labs, LLC (incorporated by reference as Exhibit 10.4 to Form 8-K filed on February 21, 2019)
10.9	Registration Rights Agreement with EcoXtraction LLC (incorporated by reference as Exhibit 10.5 to Form 8-K filed on February 21, 2019)
31.1	Certification of Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a))
31.2	Certification of Principal Financial Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a))
32.1	Certification of Principal Executive Officer  pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2	Certification of Principal Financial Officer  pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NEW BRIDGE GLOBAL VENTURES, INC.

Date:	July 11, 2019	By:	/s/ Robert K. Bench
			Robert K. Bench, Interim Chief Executive Officer

Date:	July 11, 2019	By:	/s/ Robert K Bench
			Robert K Bench, Principal Financial Officer

26

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2019	Jun. 30, 2019
Document and Entity Information:
Registrant Name	NEWBRIDGE GLOBAL VENTURES, INC.
Registrant CIK	0000726293
SEC Form	10-Q
Period End date	Mar. 31, 2019
Fiscal Year End	--12-31
Tax Identification Number (TIN)	84-1089377
Number of common stock shares outstanding		63,098,055
Entity's Reporting Status Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Entity Interactive Data Current	Yes
File Number	0-11730
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	825 East 800 North
Entity Address, City or Town	Orem
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84097
City Area Code	801
Local Phone Number	362-2115

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 38,688	$ 89,550
Prepaid expenses and other current assets	105,587	17,421
Total current assets	144,275	106,971
Operating lease right-of-use asset	254,199	258,276
Property and equipment, net	7,724,179	5,247,309
Intangible assets, net	2,644,246	0
Goodwill	9,245,953	9,245,953
Investment in joint venture	39,912	0
Other assets	4,424	0
Total Assets	20,057,188	14,858,509
Current Liabilities
Accounts payable	1,886,273	740,660
Accrued liabilities	706,517	314,715
Related party payables	941,584	106,093
Notes payable related parties	872,169	958,467
Current portion of operating lease liability	17,362	16,935
Current portion of notes payable, net of discount	20,109	23,355
Convertible notes payable, net of discount	537,494	0
Total current liabilities	4,981,508	2,160,225
Operating lease liability, net of current portion	236,837	241,341
Notes payable, net of current portion and discount	709,781	710,972
Total Liabilities	5,928,126	3,112,538
Commitments and Contingencies	0	0
STOCKHOLDERS' EQUITY
Preferred stock, $.0001 par value, 400,000 shares authorized; no shares issued and outstanding	0	0
Common stock $.0001 par value, 100,000,000 shares authorized; 59,698,055 and 57,116,055 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively.	5,970	5,712
Additional paid-in capital	19,679,205	15,209,596
Accumulated deficit	(5,556,113)	(3,469,337)
Total stockholders' equity	14,129,062	11,745,971
Total Liabilities and Stockholders' Equity	$ 20,057,188	$ 14,858,509

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Preferred Stock, par or stated value	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	400,000	400,000
Preferred Stock, shares issued	0	0
Preferred Stock, shares outstanding	0	0
Common Stock, par or stated value	$ 0.0001	$ 0.0001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	59,698,055	57,116,055
Common Stock, shares outstanding	59,698,055	57,116,055

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue:
Rental income	$ 0	$ 3,600
Consulting services	22,725	0
Total Revenue	22,725	3,600
Operating Expenses:
Selling, general and administrative	1,765,654	55,853
Total Operating Expenses	1,765,654	55,853
Loss from Operations	(1,742,929)	(52,253)
Other Expense:
Loss on investment in joint venture	(12,538)	0
Interest expense	(331,309)	(4,391)
Total Other Expense	(343,847)	(4,391)
Net Loss	$ (2,086,776)	$ (56,644)
Net loss per common share - basic and diluted	$ (0.04)	$ (0.01)
Weighted average common shares outstanding - basic and diluted	58,546,944	5,173,979

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Equity Balance, beginning of period, Value at Dec. 31, 2017	$ 370	$ 1,961,273	$ (122,253)	$ 1,839,390
Equity Balance, beginning of period, Shares at Dec. 31, 2017	3,695,604
Capital contributions for stock, Value	$ 434	37,276		37,710
Capital contributions for stock, Shares	4,338,750
Share-based compensation				0
Net Loss			(56,644)	(56,644)
Equity Balance, end of period, Value at Mar. 31, 2018	$ 804	1,998,549	(178,897)	1,820,456
Equity Balance, end of period, Shares at Mar. 31, 2018	8,034,354
Equity Balance, beginning of period, Value at Dec. 31, 2018	$ 5,712	15,209,596	(3,469,337)	11,745,971
Equity Balance, beginning of period, Shares at Dec. 31, 2018	57,116,055
Stock issued for services, Value	$ 23	294,057		294,080
Stock issued for services, Shares	232,000
Stock issued in asset acquisition, Value	$ 235	3,031,265		3,031,500
Stock issued in asset acquisition, Shares	2,350,000
Debt discount on convertible debt		1,031,040		1,031,040
Share-based compensation		113,247		113,247
Net Loss			(2,086,776)	(2,086,776)
Equity Balance, end of period, Value at Mar. 31, 2019	$ 5,970	$ 19,679,205	$ (5,556,113)	$ 14,129,062
Equity Balance, end of period, Shares at Mar. 31, 2019	59,698,055

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash Flows From Operating Activities
Net loss	$ (2,086,776)	$ (56,644)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	18,009	15,595
Amortization expense	176,284	0
Share-based compensation	113,247	0
Stock issued for services	294,080	0
Amortization of debt discount	239,040	0
Loss on investment in joint venture	12,538	0
Noncash lease expense	4,077	0
Operating expenses and interest paid through member contributions	0	34,544
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(88,166)	0
Accounts payable	27,264	0
Accrued liabilities	465,998	0
Related party payables	(75,073)	8,500
Operating lease liability	(4,077)	0
Other assets	(4,424)	0
Net Cash Provided by (Used in) Operating Activities	(907,979)	1,995
Cash Flows From Investing Activities
Purchase of property and equipment	(307,446)	0
Net Cash Used in Investing Activities	(307,446)	0
Cash Flows From Financing Activities
Proceeds from issuance of convertible notes payable	1,304,000	0
Principal payments on notes payable	(4,437)	0
Principal payments on unsecured notes payable, related parties	(135,000)	0
Net Cash Provided by Financing Activities	1,164,563	0
Net Increase (Decrease) in Cash	(50,862)	1,995
Cash at Beginning of Year	89,550	0
Cash at End of Year	38,688	1,995
Noncash Investing and Financing Information:
Long-term assets purchased through share issuance	3,031,500	0
Long-term assets purchased through accounts payable	1,118,349	0
Long-term assets purchased through related party payables	910,564	0
Long-term assets contributed to joint venture	52,450	0
Debt discount on convertible notes payable	1,031,040	0
Payments on note payable through member contributions	0	3,166
Operating expenses paid through member contributions	$ 0	$ 34,544

XML

Note 1 - The Company and Basis of Presentation

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 1 - The Company and Basis of Presentation

NOTE 1 — THE COMPANY AND BASIS OF PRESENTATION

Financial Statement Presentation and principles of consolidation – The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America and include the operations and balances of NewBridge Global Ventures, Inc. (“NewBridge”) and its wholly-owned subsidiaries, Elevated Education, Inc. (“Elevated”), 5Leaf, LLC (“5Leaf”), Genus Management Group, LLC (“Genus”), Mad Creek Farm, LLC (“Mad Creek”), 725 E 11th, LLC (“11th Street”), Timothy Lane LLC (“Timothy”), East 10^th Street LLC (“10^th Street”), The Bay Clonery, LLC (“Bay Clonery”), Roots of Caly, LLC (“Roots”), and 50% owned subsidiary Green Thumb Distributors, Inc. (“Green Thumb”). The consolidated financial statements include the operations of NewBridge and Elevated since July 14, 2018 which operations are continuing (see Reverse Acquisition below).  Genus, Timothy, 10^th Street, Green Thumb, Bay Clonery, and Roots were formed in 2018 (collectively, “New Entities”, “we”, or “the Company”).  Intercompany balances and transactions have been eliminated in consolidation.

Organization – On July 14, 2018, NewBridge closed on Share Exchange and Purchase Agreements (the “Purchase Agreements”, the “July Acquisitions”, the “Closing”) with the various members and shareholders of 11^th Street, Mad Creek, Timothy, Genus (formerly GLML) and 5Leaf (together the “Consortium”), whereby NewBridge purchased the shares or membership interests of the several entities making up the Consortium for a combined 31,000,000 shares of the Company’s common stock, par value $0.0001 per share. The Consortium consists of a farm, nursery, extraction facility, and management and real estate companies in the cannabis industry.  

Reverse Acquisition – The 31,000,000 shares issued to the Consortium represented 76% of the 40,904,589 shares of the Company’s common stock issued and outstanding immediately following the July Acquisitions. In addition, three of the four board members were replaced by the sellers at the Close. Due to the relative size of the Consortium compared to the Company prior to the Closing and the change in control of the Company, the July Acquisitions were considered a reverse acquisition and the Consortium is the acquirer for accounting purposes.  The historical financial statements are of the Consortium.

Nature of Business – The Company is vertically integrated and through its subsidiaries intends to cultivate, manufacture, and distribute industrial hemp throughout the United States and medical and recreational cannabis in California as follows:

·    Mad Creek Farm—plans to be a grower of cannabis, 

·    5Leaf—plans to manufacture and extract oils from hemp and cannabis, 

·    Green Thumb—has applied for a California Type 11 license in the Bay area, 

·    Genus—plans to provide consulting services to cultivators, processors and retailers.  

·    Elevated Education—is creating and plans to market curriculum focused on the endocannabinoid system, pharmacology and clinical applications of medical cannabis. 

·    Bay Clonery—plans to operate as an indoor nursery and tissue culture lab and to cultivate and market cannabis clones. 

·    10^th Street, 11^th Street, and Timothy Lane—will operate as real estate holding companies. 

·    Roots of Caly—plans to operate as an indoor nursery and to cultivate and market cannabis clones. 

XML

Note 2 - Going Concern

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 2 - Going Concern

NOTE 2 – GOING CONCERN

The accompanying condensed consolidated financial statements have been prepared with the recognition that there is considerable doubt about whether the Company can continue as a going concern.  As shown in the accompanying condensed consolidated financial statements, the Company incurred a net loss of $2,086,776 for the three months ended March 31, 2019 and has an accumulated deficit of $5,556,113 at March 31, 2019.  The Company also used cash in operating activities of $907,979 during the three months ended March 31, 2019.   The Company is also in default on its notes payable related party and has construction liens on some of its property.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.

XML

Note 3 - Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 3 - Summary of Significant Accounting Policies

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Information – The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the SEC.  Accordingly, they are condensed and do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements.  In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal recurring nature.  The results of operations for the three months ended March 31, 2019, may not be indicative of the results that may be expected for the year ending December 31, 2019.

These financial statements should be read in conjunction with the financial statements and notes thereto which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.

Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  

Fair Value – The fair values of the Company’s financial assets and liabilities approximate their carrying amounts at the reporting date.

Cash and Cash Equivalents – The balance in cash and cash equivalents consists of cash reserves held in bank accounts. The Company maintains cash balances in bank accounts that, at times, exceed federally insured limits.  The Company has not experienced any losses in these accounts and believes it is not exposed to any significant risk with respect to cash.

Property and Equipment – Property and equipment are stated at cost.  Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets.  Expenditures that materially increase values or capacities or extend useful lives of property and equipment are capitalized.  Leasehold improvements are assigned useful lives based on the shorter of their useful lives or the term of the related leases, including renewal options likely to be exercised.  Routine maintenance, repairs and renewal costs are expensed as incurred.  When property is retired or otherwise disposed of, the carrying values are removed from the property and equipment and related accumulated depreciation and amortization accounts.  

Goodwill – The Company tests its recorded goodwill for impairment annually on November 30, or more often if indicators of potential impairment exist, by determining if the carrying value of each reporting unit exceeds its estimated fair value. Factors that could trigger impairment include, but are not limited to, underperformance relative to historical or projected future operating results, significant changes in the manner of use of the acquired assets or the Company’s overall business and significant negative industry or economic trends. Future impairment reviews may require write-downs in the Company’s goodwill and could have a material adverse impact on the Company’s operating results for the periods in which such write-downs occur.  As of March 31, 2019 and 2018, goodwill was $9,245,953 and $0, respectively.

Long-Lived Assets – Long-lived assets are reviewed for impairment when events or changes in circumstances indicate the carrying values of the assets may not be fully recoverable. When this occurs, the Company reviews the values assigned to long-lived assets by analyzing the anticipated, undiscounted cash flows they generate.  When the expected future undiscounted cash flows from these assets do not exceed their carrying values, the Company estimates the fair values of such assets. Impairment is recognized to the extent the carrying values of the assets exceed their estimated fair values.  Assets held for sale are reported at the lower of their carrying values or fair values less costs to sell.

Research and Development – Research and development costs are expensed as incurred and are included in selling, general and administrative expense.

Stock-Based Compensation – The Company records compensation expense in the financial statements for stock-based awards based on the grant date fair value of those awards that are ultimately expected to vest. As such, the value of the award is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company determines the grant date fair value of the options using the Black-Scholes option-pricing model.  Stock-based compensation expense is recognized over the requisite service periods of the awards on a ratable basis, which recognizes expense for each vesting tranche of each grant starting on the grant date and finishing on the vest date for that tranche.

Revenue Recognition – The Company generates revenue through consulting arrangements, and in the future from manufacturing services, producing and selling products.  The revenue will be recognized at the point in time that the services are performed and products are sold and delivered to the customer.  This policy will be modified if necessary as the Company grows and develops multiple revenue sources. The company had rental income prior to the recent quarter.  The rental income was recognized monthly when earned and collection reasonably assured.  

Income Taxes – The Company accounts for income taxes pursuant to Accounting Standards Codification (ASC) 740, Income Taxes, which requires the use of the asset and liability method of accounting for deferred income taxes.  We recognize deferred tax liabilities and assets based on the differences between the tax basis of assets and liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years.

All allowances against deferred income tax assets are recorded in whole or in part, when it is more likely than not those deferred income tax assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

A valuation allowance is required to the extent it is more-likely-than-not that a deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits.

Basic and Diluted Loss Per Share – Basic loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period giving effect to potentially dilutive common stock equivalents.  As of March 31, 2019 and 2018, the Company had 4,834,000 and 0, respectively, common stock equivalents outstanding.    

Customer Concentration – Concentration of credit risk with respect to accounts receivable is limited due to only having a few sales. For consulting revenue, the Company had one customer account for 100% of total rental income for the three months ended March 31, 2019.  There was no consulting revenue during the three months ended March 31, 2018.   For rent revenue, the Company had one tenant account for 100% of total rent revenue for the three months ended March 31, 2018.  There was no rent revenue for the three months ended March 31, 2019.

Recent Accounting Pronouncements – In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 changes the accounting for leases. In particular, lessees will recognize lease assets and lease liabilities for operating leases. The Company adopted ASU 2016-02 on January 1, 2019 as described in Note 11.

XML

Note 4 - Changes in Accounting Principle

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Note 4 - Changes in Accounting Principle

NOTE 4 – CHANGES IN ACCOUNTING PRINCIPLE

As described in Note 6, the Company adopted Topic 842 Leases, effective January 1, 2019 resulting in the retrospective adjustment of the comparative 2018 periods presented. Prior to the application of Topic 842, the rent expense was recorded in the amount of the lease payments, adjusted on straight-line basis over the lease term. The presented condensed consolidated statement of operations and condensed consolidated statement of cash flows for the three-month period ended March 31, 2018 were not adjusted since the lease did not commence until August 1, 2018. The balance sheet presented as of December 31, 2018 is adjusted to reflect the ROU asset and operating lease liability described in Note 6.  Stockholders’ equity was not affected since the total 2018 expense remained the same.

XML

Note 5 - Asset Purchase Agreement and Joint Venture

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Note 5 - Asset Purchase Agreement and Joint Venture

NOTE 5 – ASSET PURCHASE AGREEMENT AND JOINT VENTURE

On February 14, 2019, the Company and EcoXtraction LLC, a Louisiana limited liability company (the “Seller”) entered into an Asset Purchase Agreement (the “Purchase Agreement”), pursuant to which the Company issued to the Seller an aggregate of 2,350,000 shares of the Company’s common stock par value $0.0001 per share (the “Shares”) and the Seller sold to the Company certain equipment and other tangible property. In connection with the Purchase Agreement, the Company and the Seller entered into a Lock-Up Agreement, which provides that, among other things, the Seller may not liquidate any of the Shares received in connection with the Purchase Agreement until September 30, 2020 (the “Lock-Up Agreement”). Further, in connection with the Purchase Agreement and the Lock-Up Agreement, the Company and the Seller entered into a Registration Rights Agreement, wherein the Company agreed to provide certain registration rights under the Securities Act of 1933 (the “Securities Act”) including an obligation to, within ninety (90) days following the Seller’s written request, prepare and file with the Securities and Exchange Commission (the “SEC” or the “Commission”) a Registration Statement or Registration Statements on Form S-1, or such other applicable form if Form S-1 is not available.  

The purchase accounting consisted of the following:

Machinery and equipment	$	210,970
Technology licensing rights		2,820,530
Total assets	$	3,031,500

The above table is a provisional valuation.  A formal valuation will be obtained for the year end financial statements.

The 2,350,000 shares issued on February 14, 2019 were valued at $1.29 per share, $3,031,500 in total.

The Purchase Agreement conveyed only assets; the Company did not receive any ownership interest in or to the Seller or the securities of the Seller and the Company does not consider it to be an acquisition of a business. The Company and the Seller also took steps described herein to create a joint venture (the “Joint Venture”).  

In connection with the Purchase Agreement, on February 14, 2019, the Company and the Seller entered into a License Agreement, pursuant to which Seller sub-licensed to the Company certain intellectual property relating to cannabis extraction technology which the Seller licenses from Hydro Dynamics, Inc. (“Hydro”) (the “License Agreement”). Subject to the terms of the License Agreement, the Seller grants to the Company certain licenses, including an exclusive license for an initial term of two (2) years from the effective date of the agreement (the “Exclusive License”). The Company has the option to renew the Exclusive License for two (2) successive additional terms of one (1) year each. The Company shall exercise its renewal option by giving the Seller written notice of the Company’s intent to renew the license; in consideration for each one-year renewal term, the Company shall issue to the Seller 250,000 shares of the Company’s common stock. The Company is under no obligation to renew.  

On February 14, 2019, the Company, EcoX and CleanWave entered into an Assignment and License Agreement (the “A&L Agreement”), pursuant to which the Seller agreed to assign and/or license certain intellectual property to CleanWave, and the Company agreed to contribute an aggregate of $2,000,000 of cash contributions to CleanWave (the “Cash Contribution”) such Cash Contribution being made no later than by the second anniversary of the effective date of the A&L Agreement. If the Cash Contribution is not met, then ownership of certain intellectual property described in the A&L Agreement shall revert back to EcoX, and CleanWave would execute all documents necessary to re-assign such intellectual property back to EcoX.

In connection with the Purchase Agreement, on February 15, 2019, the Company and EcoX created CleanWave Labs, LLC, a Nevada limited liability company (“CleanWave”) with each of the Company and EcoX as the members of CleanWave (the “Operating Agreement”). The Company shall own 50% of the member equity interests and 50% of the member profit interests of CleanWave. CleanWave was formed primarily for the purpose of (i) developing and exploiting certain proprietary technologies being assigned and licensed to the Company by EcoX designed to extract CBD, THC, as well as additional compounds from cannabis and hemp plants and (ii) manufacture and market equipment derived from that technology for use in extracting CBD, THC and additional compounds.  Pursuant to the terms of the Operating Agreement and in consideration of its membership interests, the Company shall provide certain equipment, as well as $2,000,000 in working capital over a two-year period, with the first $150,000 of the $2,000,000 paid to Hydro upon election to be used to pay Hydro the amount owed by EcoX to Hydro. The Company has not yet made the $150,000 payment to Hydro.

As of March 31, 2019, the Investment in CleanWave was $39,912, which consisted of $52,450 of equipment contributed from NewBridge to CleanWave, less $12,537 for NewBridge’s share of the net loss of CleanWave during the three months ended March 31, 2019.

The Company analyzed CleanWave and determined that it is a variable interest entity since the total equity investment is not sufficient to permit the entity to finance its activities without additional funding from NewBridge.  Also, neither NewBridge nor EcoX have a controlling financial interest in CleanWave since neither entity has the power to direct the activities of CleanWave that most significantly impact the economic performance of CleanWave.  This is because neither party can approve the annual budget without the other party’s agreement since neither party has a majority interest.  As a result, neither party is the primary beneficiary.  NewBridge accounted for its interest in CleanWave using the equity method.

XML

Note 6 - Operating Leases

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Note 6 - Operating Leases

NOTE 6 – OPERATING LEASES

The Company adopted Topic 842, Leases, effective January 1, 2019 and adjusted the 2018 comparative period presented by applying the new standard as of January 1, 2018. As a result, the 2018 periods presented for comparative purpose have been adjusted to reflect the application of Topic 842 with an adjustment to opening balance of stockholders’ equity at January 1, 2018 for cumulative effect of the initial application (see Note 4).

The Company leases a 4,200 square foot facility in Oakland, California for $3,500 per month. After year one, the Landlord can increase the rent to fair market value, not to exceed $3.50 per square foot.  The lease commenced August 1, 2018 and expires August 1, 2028.  The lessor is Hong So Mac, a related party.  Although possible, the Company does not anticipate an increase in the rent.    

As a result of the adoption of ASC 842, the Company recognized an operating liability with a corresponding right-of-use (“ROU”) asset of the same amount based on the present value of the minimum rental payments of the lease as of August 1, 2018.   The discount rate used to compute the present value of the minimum rental payments of the lease is the Company’s estimated borrowing rate of 10%.  The ROU asset is amortized on a straight-line basis over the remaining term of the lease, which is recorded as rent expense.

Balance sheet information related to the lease is as follows:

	March 31,			December 31,
	2019			2018
Operating lease right-of-use asset	$	254,199			258,276
Operating lease liability, current portion		(17,362	)		(16,935	)
Operating lease liability, net of current portion		(236,837	)		(241,341	)

The components of lease expense are as follows:

	March 31,		March 31,
	2019		2018
Amortization of right-of-use asset recorded as rent expense	$	4,077	$	—
Interest on lease liability included in other expense		6,423		—
Total lease cost	$	10,500	$	—

Maturities of the lease liability are as follows:

Future Minimum Lease Payments
2019	$	42,000
2020		42,000
2021		42,000
2022		42,000
2023		42,000
Thereafter		210,000
Total future minimum lease payments	$	420,000
Less: amount representing interest		(165,801)
Present value of future payments	$	254,199
Current portion		17,362
Long-term portion		236,837

Other information related to the lease:

	March 31,			March 31,
	2019			2018
Operating cash flows
Cash paid related to operating lease obligations	$	10,500		$	—
Weighted average remaining lease term (in years)
Operating leases		9.33			—
Weighted average discount rate
Operating leases		10.0	%		0.0	%

On March 31, 2019, there was a fire on the property next to the location the lease making the building uninhabitable since then.  The city removed the red tag on the property on June 17 so now the landlord can get the insurance company to assess the water damage and begin repairing the building.  It will likely continue to be uninhabitable through September 2019. According to the lease, the Company does not have to make lease payments while the building is uninhabitable and also has the option to terminate the lease if it chooses.  The Company has not made a decision yet on whether to terminate the lease and stopped paying rent until the property is fixed.  The ROU asset and lease liability will continue to decrease as originally scheduled.

XML

Note 7 - Property And Equipment

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 7 - Property And Equipment

NOTE 7 – PROPERTY AND EQUIPMENT

As of March 31, 2019, the Company’s property and equipment consists of the following:

Property and equipment consisted of the following:
	Estimated	March 31,	December 31,
	Useful Lives	2019	2018
Land	n/a	$908,271	$908,271
Buildings and improvements	5-30 years	2,391,922	2,391,922
Machinery and equipment	3-8 years	893,562	424,461
Office furniture and equipment	3-8 years	26,120	23,146
Construction in progress	n/a	3,734,847	1,712,043
Total		7,954,722	5,459,843
Less accumulated depreciation		(230,543)	(212,534)
Net property and equipment		$7,724,179	$5,247,309

For the three months ended March 31, 2019 and 2018, the Company had depreciation expense of $18,009 and $15,595, respectively.

XML

Note 8 - Intangible Assets

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Note 8 - Intangible Assets

NOTE 8 – INTANGIBLE ASSETS

As of March 31, 2019, the intangible assets consist of the following:

	Estimated	March 31,
	Useful Life	2019
Technology licensing rights	2 years	$ 2,820,530
Total		2,820,530
Less accumulated amortization		(176,284)
Net intangible assets		$ 2,644,246

The technology licensing rights were acquired as part of the asset purchase agreement (see Note 5).  The Company has an exclusive license to water extraction technology for two years and a non-exclusive license in perpetuity.  For the three months ended March 31, 2019, the Company had amortization expense of $176,284.

XML

Note 9 - Convertible Notes Payable

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 9 - Convertible Notes Payable

NOTE 9 – CONVERTIBLE NOTES PAYABLE

On January 7, 2019, the Company completed the first close on a $7.5 million private offering of securities (the “Offering”), whereby the Company entered into a Note Purchase Agreement (the “Purchase Agreement”) with certain accredited investors, pursuant to which the Company issued to those investors $1,074,000 worth of 10% convertible promissory notes, convertible into shares of the Company’s common stock, par value $0.0001 per share at a  conversion price of $1.00 per share upon the terms and subject to the conditions set forth in the Note Purchase Agreement and the Notes (the “Notes”), for a maximum of $7.5 million. The Notes have a maturity date of December 31, 2019 if not converted.  The Company recorded a beneficial conversion feature of $1,031,040 upon issuance and recognized amortization of the debt discount of $239,040 for the three months ended March 31, 2019. On March 14, 2019, the Company completed the second close and issued $230,000 worth of 10% convertible promissory notes.  The terms and maturity date are the same as those for the January 7 closing.

The convertible notes payable consists of the following:

	March 31,			December 31,
	2019			2018
Convertible notes payable	$	1,329,494		$	—
Less debt discount		(792,000	)		—
Convertible notes payable, net of discount		537,494			—
Less current portion		(537,494	)		—
Convertible notes payable, net of current portion and discount	$	—		$	—

XML

Note 10 - Notes Payable

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 10 - Notes Payable

NOTE 10 – NOTES PAYABLE

As of March 31, 2019, the Company’s notes payable consisted of bank loans of $346,041 on the Mad Creek property and $383,848 on the 10^th Street property, which was assumed when the property was deeded to the Company on September 12, 2018.  The Mad Creek loan had a variable interest rate of 4.75% as of March 31, 2019 that adjusts on May 1 and November 1 each year.  The loan matures on November 1, 2036.  The 10^th Street loan has a fixed interest rate of 9.66% and a maturity date of July 1, 2036.  

	March 31,			December 31,
	2019			2018
Note payable	$	729,890		$	734,327
Less current portion		(20,109	)		(23,355	)
Note payable, net of current portion	$	709,781		$	710,972

XML

Note 11 - Stock Options

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Note 11 - Stock Options

NOTE 11 – STOCK OPTIONS

As of March 31, 2019, options to purchase 3,380,000 shares of common stock under the Company’s stock option plan were authorized and reserved for future grant.  A summary of activity in the stock option plan for the three months ended March 31, 2019 is as follows:

	2019
			Weighted-
			Average
	Number		Exercise
	of Shares		Price
Outstanding as of beginning of the period		1,580,000	$	0.25
Granted		1,950,000		0.89
Exercised		—		—
Forfeited or expired		—		—
Outstanding as of end of the period		3,530,000		0.60
Exercisable as of end of the period		3,530,000		0.60

As of March 31, 2019, options exercisable and options outstanding had a weighted average remaining contractual term of 3.04 years and had an aggregate intrinsic value of $584,216.

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for the grants made in the three months ended March 31, 2019:

	2019
Expected life (in years)	3.04
Risk free rate	2.9%
Volatility	459.7%
Dividend yield	-

Expected option life and volatility are based on historical data of the Company.   The risk-free interest rate is calculated based on the average US Treasury bill rate that corresponds with the option life.  Historically, the Company has not declared dividends and there are no foreseeable plans to do so.

As of March 31, 2019, there was $2,815,924 of unrecognized share-based compensation cost related to grants under the stock option plans that will be recognized over a weighted-average period of 3 years.

Share-based compensation expense included in selling, general and administrative expense in the statements of income for each of the three-month periods ended March 31, 2019 and 2018 was $113,247 and $0, respectively.

XML

Note 12 - Stockholders' Equity

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 12 - Shareholders' Equity

NOTE 12 – SHAREHOLDERS’ EQUITY

We have authorized capital stock consisting of 100,000,000 shares of $0.0001 par value common stock and 400,000 shares of $0.0001 par value preferred stock. At March 31, 2019 and December 31, 2018, we had 59,698,055 and 57,116,055 shares of common stock issued and outstanding, respectively, and no shares of preferred stock issued and outstanding.

During January 2019, the Company issued 32,000 shares to Patrick Tang for compensation through March 31, 2019 and issued 200,000 shares to John MacKay as a signing bonus.  The Company recognized share-based compensation of $46,080 and $248,000, respectively, related to these issuances.  The value was based on the fair value of the Company’s common stock.

On February 14, 2019, the Company issued 2,350,000 shares to EcoXtraction LLC for the asset acquisition as described in Note 5.  The shares were valued at $1.29 per share for a total valuation of $3,031,500. The value was based on the fair value of the Company’s common stock.

XML

Note 13 - Commitments And Contingencies

3 Months Ended

Mar. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Note 13 - Commitments And Contingencies

NOTE 13 – COMMITMENTS AND CONTINGENCIES

As discussed in Note 5, the Company is committed to contributing $2,000,000 to CleanWave by February 14, 2021 to fund the joint venture’s operations.  

XML

Note 14 - Related Party Transactions

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 14 - Related Party Transactions

NOTE 14 – RELATED PARTY TRANSACTIONS

The Company is leasing 4200 square feet of property from Hong So Mac, the father of Sam Mac, one of the principal shareholders (see Note 6).  Total rent payments of $10,500 were made for the three months ended March 31, 2019.  

On December 31, 2018, the Company issued notes payable of $958,467 to several of its principal shareholders, members of management and affiliated companies.  The notes have been classified as notes payable related party.  The notes bear interest at 8% and carry either a $5,000 or $1,000 late fee if not paid in full by March 31, 2019, the maturity date.  A few of the notes had due dates on March 28, 2019.  The interest increases to 12% for unpaid balances after the maturity date.  The notes are unsecured except for one note for $261,650 which is secured by equipment that was purchased with the funds from the note. Most of the remaining balance is payable to Tran Millenium, a company owned by Eric Tran, for consulting related to the formation, strategy, permitting, licensing, compliance and construction design for the new entities formed during 2018.  As of March 31, 2019, the Company had paid back $135,000 of the notes payable related party but was in default on the rest.  As of March 31, 2019, the Company had notes payable related parties of $872,169, which includes interest and penalties of $48,703.

As of March 31, 2019 and December 31, 2018, the Company had related party payables of $941,584 and $106,093, respectively, for reimbursable expenses.

XML

Note 15 - Management Changes

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Note 15 - Management Changes

NOTE 15 – MANAGEMENT CHANGES

On January 17, 2019, the Company announced the expansion of its corporate management team with the appointments of Dr. John MacKay as Chief Technology Officer (“CTO”), Patrick P. Tang as Chief Compliance Officer (“CCO”) and Sandra Ribble as Corporate Controller of Newbridge Global Ventures.  

Dr. John MacKay’s employment agreement commenced January 2, 2019 and terminates on December 31, 2021, with extensions upon mutual agreement.  His base salary is $10,000 per month and he will be issued 200,000 shares of the Company’s Common Stock par value $0.0001 as a signing bonus and he will be eligible for an annual bonus.

Patrick Tang’s employment agreement commences March 1, 2019 and terminating on December 31, 2020, with extensions upon mutual agreement.  His base salary is $10,000 per month for March thru December 2019 and then $15,000 per month for the twelve months ended December 2020.  Patrick will also be granted options to acquire 300,000 shares of the Company’s Common Stock par value $0.0001 and will be eligible for an annual bonus.  Also, on December 18, 2018, the Company signed an interim services agreement with Patrick Tang in which he received 32,000 shares of common stock for interim services from December 18, 2018 through March 2019.

On January 18, 2019, the Company granted non-statutory stock options of 1,000,000 to Synergistic Technologies Associates, LLC (a company owned by Dr. John MacKay) and 300,000 to Patrick Tang.  The options have an exercise price of $1.00 per share.

On January 17, 2019, the Board approved the 2019 Equity Incentive Plan (“2019 Incentive Plan”) in order to attract and retain qualified personnel, directors and consultants and align their interests with those of the Company’s stockholders.  The 2019 Incentive Plan reserves 5,000,000 shares of the Company’s common stock, par value $0.000l for future issuance.  The option exercise price will be set by a committee but will not be less than the fair market value of the common stock at the time of the grant.

On January 17, 2019, the Board approved the appointment of Ellen Gee as President of 5Leaf, LLC, replacing Dr. John MacKay.

On April 16, 2019, the Board appointed Arthur Kwan to the Company’s Board effective immediately.

On May 10, 2019, the Board appointed Eric Baum to the Company’s Board effective immediately.

On June 6, 2019, the Company terminated Eric Tran from his position as Chief Strategy Officer of NewBridge Global Ventures, Inc. and from his employment and directorship positions with each of the Company’s subsidiaries. Mr. Tran will remain a Director of the Company. 

XML

Note 16 - Subsequent Event

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

Note 16 - Subsequent Event

NOTE 16 – SUBSEQUENT EVENTS

On April 9, 2016, effective as of April 16, 2019, the Company entered into a consulting agreement with Aston Capital where it agreed to issue to Mr. Kwan an aggregate of 250,000 shares of the Company’s common stock, par value $0.0001 and granted to Mr. Kwan options to purchase an aggregate of 250,000 shares of common stock of the Company at a strike price of $0.65 per share.

On April 12, 2019, the Company and Hydro Dynamics, Inc., a Georgia corporation (“Hydro”) entered into a technology license agreement (the “Agreement”), whereby the Company would license from Hydro certain Hydro-owned technology and associated intellectual property including the ShockWave Power Reactor/Extractor, such intellectual property being useful in a variety of industries including but not limited to those industries which extract, mix, heat, hydrate, homogenize and crystallize materials (the “Hydro Technology”). Pursuant to the terms and subject to the conditions set forth in the Agreement, the Company shall, in consideration for licensing the Hydro Technology from Hydro, furnish to Hydro: (i) a one-time lump-sum cash payment of $60,000 (the “Cash Payment”) no later than July 3, 2019; (ii) four semiannual payments of $125,000 each for an aggregate of $500,000 in payments beginning on January 15, 2020 and culminating with a final payment on July 15, 2021, such $500,000 is convertible into shares of the Company’s common stock, par value $0.0001 per share at a conversion price of $1.00 per share or the market price at the time of conversion but not less than $0.75 per share; (iii) 2,125,000 shares of the Company’s Common Stock (the “Stock Payment”) and (iv) an annual license fee of $100,000 no later than January 15 of each year of the Term beginning in 2022. In addition to these fees, Hydro and the Company agreed to enter into a revenue-sharing plan whereby the Company will furnish to Hydro 3% of net revenues from the Company derived by the Company’s sale or lease of certain technologies (the “Revenue-Sharing Arrangement”) and Hydro is further permitted to sell certain stand-alone products to third-parties in exchange for paying to the Company a participation fee for any such third-party sales. The agreement is perpetual, subject to the Company’s right to terminate the agreement at the end of the Company’s 2025 fiscal year. 

On April 17, 2019, the Company and King Hemp Farm NM, LLC, a New Mexico limited liability company (“King”), entered into an operating agreement (the “Operating Agreement”), pursuant to which the Companies formed King Hemp Farm LLC, a Nevada limited liability company (the “Joint Venture”). The Companies formed the Joint Venture primarily for the purpose of exploiting certain farming operations to raise hemp on properties controlled by King and to extract CBD and additional compounds from hemp plants. In connection with the Operating Agreement, King granted the Company two 10-year leases on at least 10 acres of land controlled by King. The managers of the Joint Venture are initially Robert Bench, the Company’s interim Chief Executive Officer, and Tyler King. The members of the Joint Venture are the Company and King, each with a 50% membership interest, with payment from the proceeds generated by the Joint Venture to be distributed in accord with the respective capital contributions of each of the Company and King.  King agreed to cultivate 50 acres of land in 2019 and the Company issued 1,000,000 shares, valued at $0.50 per share to King during April 2019.  

On May 1, 2019, the Company and Innovative Separations, LLC, an Oregon limited liability company (“Innovative”) together with Joseph Mazza, the managing member of Innovative (“Mr. Mazza”) entered into a letter of intent, pursuant to which the Company and Innovative will be joint partners for the purpose of exploiting certain farming operations that raise cannabis and hemp and to extract CBD, THC and other compounds from cannabis and hemp plants through the use of certain technologies and equipment (the “Innovative Transaction”). Pursuant to the terms of the letter of intent and subject to the conditions to be set forth in an Operating Agreement, the Company may: (i) issue 25,000 shares of the Company’s common stock to Mr. Mazza, and 25,000 shares of the Company’s common stock to the Gary and Gail Harstein Family Trust; (ii) enter into a lease purchase option to purchase certain property listed in the Operating Agreement; (iii) place at least one Company ShockWave Power™ Reactor in Innovative and (iv) provide cash for working capital of up to $200,000 over a one-year period. In addition to the Innovative joint venture, the Company will receive the right to use certain trade names and access to certain lands currently owned by Innovative (together with the Innovative joint venture, the “Innovative Interests”). The term proposed Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement. The Operating Agreement may also provides for certain drag-along provisions, whereby the Managers may require any members of Innovative to sell their respective Innovative MIs to a proposed purchaser.  

On May 2, 2019, the Company and Apothio, LLC, a Colorado limited liability company (“Apothio”) entered into an operating agreement (the “Operating Agreement”), pursuant to which the Company and Apothio agreed to form Apothio Bakersfield, LLC, a Nevada limited liability company (the “Joint Venture”), whereby pursuant to the terms and subject to the conditions set forth in the Operating Agreement, the Company and Apothio shall each receive fifty percent (50%) of the membership interests in the Joint Venture. Under the terms of the Operating Agreement, the Company will be required to: (i) underwrite costs to contribute extraction equipment; (ii) fund the cost of a fully-functional extraction facility and (iii) install a fully-functional testing laboratory with certain equipment as determined by the managers of the Joint Venture. Apothio will contribute existing biomass of approximately 150,000 pounds for the Company to begin processing and extraction, and will contribute some of its 512 acres of plants. The term of the Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement.  The Operating Agreement also provides for certain drag-along provisions, whereby the managers may require any members of the Joint Venture to sell their respective membership interests to a proposed purchaser.  

XML

Note 3 - Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2019

Policy Text Block [Abstract]

Interim Financial Information

Interim Financial Information – The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the SEC.  Accordingly, they are condensed and do not include all of the information and notes required by accounting principles generally accepted in the United States of America for complete financial statements.  In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal recurring nature.  The results of operations for the three months ended March 31, 2019, may not be indicative of the results that may be expected for the year ending December 31, 2019.

These financial statements should be read in conjunction with the financial statements and notes thereto which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. The accounting policies set forth in those annual financial statements are the same as the accounting policies utilized in the preparation of these financial statements, except as modified for appropriate interim financial statement presentation.

Use of Estimates

Use of Estimates – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  

Fair Value

Fair Value – The fair values of the Company’s financial assets and liabilities approximate their carrying amounts at the reporting date.

Cash and Cash Equivalents

Cash and Cash Equivalents – The balance in cash and cash equivalents consists of cash reserves held in bank accounts. The Company maintains cash balances in bank accounts that, at times, exceed federally insured limits.  The Company has not experienced any losses in these accounts and believes it is not exposed to any significant risk with respect to cash.

Property and Equipment

Property and Equipment – Property and equipment are stated at cost.  Depreciation is computed using the straight-line method based on the estimated useful lives of the related assets.  Expenditures that materially increase values or capacities or extend useful lives of property and equipment are capitalized.  Leasehold improvements are assigned useful lives based on the shorter of their useful lives or the term of the related leases, including renewal options likely to be exercised.  Routine maintenance, repairs and renewal costs are expensed as incurred.  When property is retired or otherwise disposed of, the carrying values are removed from the property and equipment and related accumulated depreciation and amortization accounts.  

Goodwill

Goodwill – The Company tests its recorded goodwill for impairment annually on November 30, or more often if indicators of potential impairment exist, by determining if the carrying value of each reporting unit exceeds its estimated fair value. Factors that could trigger impairment include, but are not limited to, underperformance relative to historical or projected future operating results, significant changes in the manner of use of the acquired assets or the Company’s overall business and significant negative industry or economic trends. Future impairment reviews may require write-downs in the Company’s goodwill and could have a material adverse impact on the Company’s operating results for the periods in which such write-downs occur.  As of March 31, 2019 and 2018, goodwill was $9,245,953 and $0, respectively.

Long-Lived Assets

Long-Lived Assets – Long-lived assets are reviewed for impairment when events or changes in circumstances indicate the carrying values of the assets may not be fully recoverable. When this occurs, the Company reviews the values assigned to long-lived assets by analyzing the anticipated, undiscounted cash flows they generate.  When the expected future undiscounted cash flows from these assets do not exceed their carrying values, the Company estimates the fair values of such assets. Impairment is recognized to the extent the carrying values of the assets exceed their estimated fair values.  Assets held for sale are reported at the lower of their carrying values or fair values less costs to sell.

Research and Development

Research and Development – Research and development costs are expensed as incurred and are included in selling, general and administrative expense.

Stock-Based Compensation

Stock-Based Compensation – The Company records compensation expense in the financial statements for stock-based awards based on the grant date fair value of those awards that are ultimately expected to vest. As such, the value of the award is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company determines the grant date fair value of the options using the Black-Scholes option-pricing model.  Stock-based compensation expense is recognized over the requisite service periods of the awards on a ratable basis, which recognizes expense for each vesting tranche of each grant starting on the grant date and finishing on the vest date for that tranche.

Revenue Recognition

Revenue Recognition – The Company generates revenue through consulting arrangements, and in the future from manufacturing services, producing and selling products.  The revenue will be recognized at the point in time that the services are performed and products are sold and delivered to the customer.  This policy will be modified if necessary as the Company grows and develops multiple revenue sources. The company had rental income prior to the recent quarter.  The rental income was recognized monthly when earned and collection reasonably assured.  

Income Taxes

Income Taxes – The Company accounts for income taxes pursuant to Accounting Standards Codification (ASC) 740, Income Taxes, which requires the use of the asset and liability method of accounting for deferred income taxes.  We recognize deferred tax liabilities and assets based on the differences between the tax basis of assets and liabilities and their reported amounts in the financial statements that will result in taxable or deductible amounts in future years.

All allowances against deferred income tax assets are recorded in whole or in part, when it is more likely than not those deferred income tax assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.

A valuation allowance is required to the extent it is more-likely-than-not that a deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits.

Basic and Diluted Loss Per Share

Basic and Diluted Loss Per Share – Basic loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period giving effect to potentially dilutive common stock equivalents.  As of March 31, 2019 and 2018, the Company had 4,834,000 and 0, respectively, common stock equivalents outstanding.    

Customer Concentration

Customer Concentration – Concentration of credit risk with respect to accounts receivable is limited due to only having a few sales. For consulting revenue, the Company had one customer account for 100% of total rental income for the three months ended March 31, 2019.  There was no consulting revenue during the three months ended March 31, 2018.   For rent revenue, the Company had one tenant account for 100% of total rent revenue for the three months ended March 31, 2018.  There was no rent revenue for the three months ended March 31, 2019.

Recent Accounting Pronouncements

Recent Accounting Pronouncements – In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-02, Leases (Topic 842) ("ASU 2016-02"). ASU 2016-02 changes the accounting for leases. In particular, lessees will recognize lease assets and lease liabilities for operating leases. The Company adopted ASU 2016-02 on January 1, 2019 as described in Note 11.

XML

Note 5 - Asset Purchase Agreement and Joint Venture (Tables)

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Schedule of purchase accounting

The purchase accounting consisted of the following:

Machinery and equipment	$	210,970
Technology licensing rights		2,820,530
Total assets	$	3,031,500

XML

Note 6 - Operating Leases (Tables)

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Balance sheet information related to lease

Balance sheet information related to the lease is as follows:

	March 31,			December 31,
	2019			2018
Operating lease right-of-use asset	$	254,199			258,276
Operating lease liability, current portion		(17,362	)		(16,935	)
Operating lease liability, net of current portion		(236,837	)		(241,341	)

Components of lease expense

The components of lease expense are as follows:

	March 31,		March 31,
	2019		2018
Amortization of right-of-use asset recorded as rent expense	$	4,077	$	—
Interest on lease liability included in other expense		6,423		—
Total lease cost	$	10,500	$	—

Maturities of lease liability

Maturities of the lease liability are as follows:

Future Minimum Lease Payments
2019	$	42,000
2020		42,000
2021		42,000
2022		42,000
2023		42,000
Thereafter		210,000
Total future minimum lease payments	$	420,000
Less: amount representing interest		(165,801)
Present value of future payments	$	254,199
Current portion		17,362
Long-term portion		236,837

Other information related to lease

Other information related to the lease:

	March 31,			March 31,
	2019			2018
Operating cash flows
Cash paid related to operating lease obligations	$	10,500		$	—
Weighted average remaining lease term (in years)
Operating leases		9.33			—
Weighted average discount rate
Operating leases		10.0	%		0.0	%

XML

Note 7 - Property And Equipment (Tables)

3 Months Ended

Mar. 31, 2019

Table Text Block Supplement [Abstract]

Schedule of Property Plant And Equipment

Property and equipment consisted of the following:
	Estimated	March 31,	December 31,
	Useful Lives	2019	2018
Land	n/a	$908,271	$908,271
Buildings and improvements	5-30 years	2,391,922	2,391,922
Machinery and equipment	3-8 years	893,562	424,461
Office furniture and equipment	3-8 years	26,120	23,146
Construction in progress	n/a	3,734,847	1,712,043
Total		7,954,722	5,459,843
Less accumulated depreciation		(230,543)	(212,534)
Net property and equipment		$7,724,179	$5,247,309

XML

Note 8 - Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of intangible assets

As of March 31, 2019, the intangible assets consist of the following:

	Estimated	March 31,
	Useful Life	2019
Technology licensing rights	2 years	$ 2,820,530
Total		2,820,530
Less accumulated amortization		(176,284)
Net intangible assets		$ 2,644,246

XML

Note 9 - Convertible Notes Payable (Tables)

3 Months Ended

Mar. 31, 2019

Disclosure Text Block [Abstract]

Schedule of convertible notes payable

The convertible notes payable consists of the following:

	March 31,			December 31,
	2019			2018
Convertible notes payable	$	1,329,494		$	—
Less debt discount		(792,000	)		—
Convertible notes payable, net of discount		537,494			—
Less current portion		(537,494	)		—
Convertible notes payable, net of current portion and discount	$	—		$	—

XML

Note 10 - Notes Payable (Tables)

3 Months Ended

Mar. 31, 2019

Table Text Block Supplement [Abstract]

Schedule of Note Payable

	March 31,			December 31,
	2019			2018
Note payable	$	729,890		$	734,327
Less current portion		(20,109	)		(23,355	)
Note payable, net of current portion	$	709,781		$	710,972

XML

Note 11 - Stock Options (Tables)

3 Months Ended

Mar. 31, 2019

Notes to Financial Statements

Schedule Of Share Based Compensation Stock Options Activity

A summary of activity in the stock option plan for the three months ended March 31, 2019 is as follows:

	2019
			Weighted-
			Average
	Number		Exercise
	of Shares		Price
Outstanding as of beginning of the period		1,580,000	$	0.25
Granted		1,950,000		0.89
Exercised		—		—
Forfeited or expired		—		—
Outstanding as of end of the period		3,530,000		0.60
Exercisable as of end of the period		3,530,000		0.60

Schedule of Stock Options, Valuation Assumptions

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions used for the grants made in the three months ended March 31, 2019:

	2019
Expected life (in years)	3.04
Risk free rate	2.9%
Volatility	459.7%
Dividend yield	-

XML

Note 1 - The Company and Basis of Presentation (Details) - shares	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Common Stock, Shares, Outstanding	59,698,055	57,116,055
Common Stock
Reverse merger	2,350,000
Common Stock | Consortium
Reverse merger	31,000,000
Common Stock, Shares, Outstanding	40,904,589

XML

Note 2 - Going Concern (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Text Block [Abstract]
Net loss	$ (2,086,776)	$ (56,644)
Accumulated deficit	(5,556,113)		$ (3,469,337)
Net Cash Used in Operating Activities	$ (907,979)	$ 1,995

XML

Note 3 - Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Goodwill	$ 9,245,953	$ 0	$ 9,245,953
Options outstanding	3,530,000	0	1,580,000
Consulting Revenue [Member] | One Customer [Member]
Concentration percentage	100.00%	0.00%
Rent Revenue [Member] | OneTenant [Member]
Concentration percentage	100.00%	0.00%

XML

Note 5 - Asset Purchase Agreement and Joint Venture (Details) - USD ($)	1 Months Ended		3 Months Ended
	Feb. 15, 2019	Feb. 14, 2019	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Share Price		$ 1.29
Common stock issued			59,698,055		57,116,055
Stock issued		2,350,000
Value of stock issued		$ 3,031,500
Investment			$ 39,912		$ 0
Net Loss			(2,086,776)	$ (56,644)
CleanWave
Investment			39,912
Equipment contributed			52,450
Net Loss			$ (12,537)
Asset Purchase Agreement
Share Price		$ 0.0001
Common stock issued		2,350,000
License Agreement | Hydro
Common stock issued		250,000
Assignment and License Agreement | CleanWave
Cash contribution		$ 2,000,000
Equipment description	Pursuant to the terms of the Operating Agreement and in consideration of its membership interests, the Company shall provide certain equipment, as well as $2,000,000 in working capital over a two-year period, with the first $150,000 of the $2,000,000 paid to Hydro upon election to be used to pay Hydro the amount owed by EcoX to Hydro. The Company has not yet made the $150,000 payment to Hydro.

XML

Note 5 - Asset Purchase Agreement and Joint Venture : Schedule of purchase accounting (Details) - USD ($)	Mar. 31, 2019	Feb. 14, 2019	Dec. 31, 2018
Notes to Financial Statements
Machinery and equipment		$ 210,970
Technology licensing rights		2,820,530
Total Assets	$ 20,057,188	$ 3,031,500	$ 14,858,509

XML

Note 6 - Operating Leases (Details)	3 Months Ended
	Mar. 31, 2019 USD ($) a
Lease commencement date	Aug. 01, 2018
Lease Expiration Date	Aug. 01, 2028
Lessee, Operating Lease, Discount Rate	10.00%
CALIFORNIA
Area of Land | a	4,200
Lease amount per month | $	$ 3,500

XML

Note 6 - Operating Leases: Balance sheet information related to lease (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Notes to Financial Statements
Operating lease right-of-use asset	$ 254,199	$ 258,276
Operating lease liability, current portion	(17,362)	(16,935)
Operating lease liability, net of current portion	$ 236,837	$ 241,341

XML

Note 6 - Operating Leases: Components of lease expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Notes to Financial Statements
Amortization of right-of-use asset recorded as rent expense	$ 4,077	$ 0
Interest on lease liability included in other expense	6,423	0
Total lease cost	$ 10,500	$ 0

XML

Note 6 - Operating Leases: Maturities of the lease liability (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Notes to Financial Statements
2019	$ 42,000
2020	42,000
2021	42,000
2022	42,000
2023	42,000
Thereafter	210,000
Total future minimum lease payments	420,000
Less: amount representing interest	(165,801)
Present value of future payments	254,199
Operating lease liability, current portion	17,362	$ 16,935
Operating lease liability, net of current portion	$ 236,837	$ 241,341

XML

Note 6 - Operating Leases: Other information related to lease (Details) - USD ($)	Mar. 31, 2019	Mar. 31, 2018
Operating cash flows
Cash paid related to operating lease obligations	$ 10,500	$ 0
Weighted average remaining lease term (in years) Operating leases	9 years 3 months 29 days
Weighted average discount rate Operating leases	10.00%	0.00%

XML

Note 7 - Property And Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Disclosure Text Block [Abstract]
Depreciation expense	$ 18,009	$ 15,595

XML

Note 7 - Property And Equipment: Schedule of Property Plant And Equipment (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment, Gross	$ 7,954,722	$ 5,459,843
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	(230,543)	(212,534)
Property and equipment, net	7,724,179	5,247,309
Buildings and improvements
Property, Plant and Equipment, Gross	$ 2,391,922	2,391,922
Buildings and improvements | Minimum
Property, Plant and Equipment, Useful Life	5 years
Buildings and improvements | Maximum
Property, Plant and Equipment, Useful Life	30 years
Machinery and Equipment [Member]
Property, Plant and Equipment, Gross	$ 893,562	424,461
Machinery and Equipment [Member] | Minimum
Property, Plant and Equipment, Useful Life	3 years
Machinery and Equipment [Member] | Maximum
Property, Plant and Equipment, Useful Life	8 years
Office furniture and equipment
Property, Plant and Equipment, Gross	$ 26,120	23,146
Office furniture and equipment | Minimum
Property, Plant and Equipment, Useful Life	3 years
Office furniture and equipment | Maximum
Property, Plant and Equipment, Useful Life	8 years
Land
Property, Plant and Equipment, Gross	$ 908,271	908,271
Construction in Progress
Property, Plant and Equipment, Gross	$ 3,734,847	$ 1,712,043

XML

Note 8 - Intangible Assets (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 176,284	$ 0

XML

Note 8 - Intangible Assets: Schedule of intangible assets (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Technology licensing rights	2 years
Total	$ 2,820,530
Less accumulated amortization	(176,284)
Net intangible assets	2,644,246	$ 0
Technology licensing rights
Total	$ 2,820,530

XML

Note 9 - Convertible Notes Payable (Details) - USD ($)			3 Months Ended
	Mar. 14, 2019	Jan. 08, 2019	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Common stock par value			$ 0.0001		$ 0.0001
Debt Instrument, Convertible, Beneficial Conversion Feature			$ 1,031,040
Amortization of debt discount			$ 239,040	$ 0
Note Purchase Agreement | Accredited Investors[Member]
Proceeds from private offering of securities		$ 7,500,000
Issuance of promissory note	$ 230,000	$ 1,074,000
Common stock par value		$ 0.0001
Conversion price		$ 1.00
Debt Instrument, Maturity Date		Dec. 31, 2019
Note Purchase Agreement | Accredited Investors[Member] | Maximum
Proceeds from private offering of securities		$ 7,500,000

XML

Note 9 - Convertible Notes Payable : Schedule of convertible notes payable (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Disclosure Text Block [Abstract]
Convertible notes payable	$ 1,329,494	$ 0
Less debt discount	(792,000)	0
Convertible notes payable, net of discount	537,494	0
Less current portion	(537,494)	0
Convertible notes payable, net of current portion and discount	$ 0	$ 0

XML

Note 10 - Notes Payable (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Notes Payable	$ 729,890	$ 734,327
East 10th Street
Notes Payable	$ 383,848
Debt Instrument, Interest Rate, Stated Percentage	9.66%
Debt Instrument, Maturity Date	Jul. 01, 2036
Mad Creek
Notes Payable	$ 346,041
Debt Instrument, Interest Rate, Stated Percentage	4.75%
Debt Instrument, Maturity Date	Nov. 01, 2036

XML

Note 10 - Notes Payable: Schedule of Note Payable (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Text Block [Abstract]
Notes Payable	$ 729,890	$ 734,327
Less current portion	(20,109)	(23,355)
Notes payable, net of current portion and discount	$ 709,781	$ 710,972

XML

Note 11 - Stock Options (Details) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Text Block [Abstract]
Stock option authorized	3,380,000
Options exercisable weighted average remaining contractual term	3 years 15 days
Options outstanding weighted average remaining contractual term	3 years 15 days
Options exercisable, Intrinsic Value	$ 584,216
Options outstanding, Intrinsic Value	584,216
Share-based compensation	113,247	$ 0
Unrecognized share-based compensation cost	$ 2,815,924
Unrecognized weighted-average period	3 years

XML

Note 11 - Stock Options : Schedule Of Share Based Compensation Stock Options Activity (Details)	3 Months Ended
	Mar. 31, 2019 $ / shares shares
Text Block [Abstract]
Options outstanding | shares	1,580,000
Options granted | shares	1,950,000
Options exercised | shares	0
Options forfeited | shares	0
Options outstanding | shares	3,530,000
Options Exercisable | shares	3,530,000
Options Outstanding per share | $ / shares	$ 0.25
Options granted per share | $ / shares	0.89
Options exercised per share | $ / shares	0.00
Options forfeited per share | $ / shares	0.00
Outstanding per share | $ / shares	0.60
Options Exercisable per share | $ / shares	$ 0.60

XML

Note 11 - Stock Options: Schedule of Stock Options, Valuation Assumptions (Details)	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Expected life (in years)	3 years 15 days
Risk free interest rate	2.90%
Expected volatility	459.70%
Dividend yield	0.00%

XML

Note 12 - Shareholders' Equity (Details) - USD ($)	1 Months Ended		3 Months Ended
	Feb. 14, 2019	Jan. 31, 2019	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018
Common Stock, Shares Authorized			100,000,000		100,000,000
Common Stock, Par or Stated Value Per Share			$ 0.0001		$ 0.0001
Preferred Stock, Shares Authorized			400,000		400,000
Preferred Stock, Par or Stated Value Per Share			$ 0.0001		$ 0.0001
Common Stock, shares issued			59,698,055		57,116,055
Common Stock, shares outstanding			59,698,055		57,116,055
Preferred Stock, shares issued			0		0
Preferred Stock, shares outstanding			0		0
Share-based compensation			$ 113,247	$ 0
Stock issued for asset acquisition, value			$ 3,031,500
EcoXtraction
Stock issued for asset acquisition, Shares	2,350,000
Stock issued for asset acquisition, value	$ 3,031,500
Share Price	$ 1.29
PatrickTang
Common stock issued for services		32,000
Share-based compensation		$ 46,080
John MacKay
Stock issued for signing bonus		200,000
Share-based compensation		$ 248,000

XML

Note 13 - Commitments And Contingencies (Details)	1 Months Ended
	Feb. 14, 2021 USD ($)
CleanWave
Additional contribution	$ 2,000,000

XML

Note 14 - Related Party Transactions (Details)	3 Months Ended
	Mar. 31, 2019 USD ($) ft²	Dec. 31, 2018 USD ($)
Text Block [Abstract]
Lease of property | ft²	4,200
Payments for Rent	$ 10,500
Related party payables	941,584	$ 106,093
Issueance of notes payable	$ 958,467
Interest rate	8.00%
Late fee	$ 5,000
Due date	Mar. 28, 2019
Note Secured by equipment	$ 261,650
Repayment of notes payable related party	135,000
Notes payable related parties	872,169	$ 958,467
Interest and penalties	$ 48,703

XML

Note 15 - Management Changes (Details) - USD ($)	1 Months Ended		3 Months Ended	10 Months Ended	12 Months Ended
	Jan. 31, 2019	Jan. 17, 2019	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2020	Feb. 14, 2019	Jan. 18, 2019	Dec. 31, 2018
Lease commencement date			Aug. 01, 2018
Lease Expiration Date			Aug. 01, 2028
Common stock par value			$ 0.0001					$ 0.0001
Common stock issued			59,698,055					57,116,055
John A. MacKay
Stock option granted		1,000,000
Option exercise price		$ 1.00
Patrick Tang
Common stock issued for services	32,000
Employment Agreement | John A. MacKay
Lease commencement date		Jan. 02, 2019
Lease Expiration Date		Dec. 31, 2021
Common stock par value		$ 0.0001
Base Salary		$ 10,000
Common stock issued		200,000
Employment Agreement | Patrick Tang
Lease commencement date		Mar. 01, 2019
Lease Expiration Date		Dec. 31, 2020
Common stock par value		$ 0.0001
Base Salary				$ 10,000	$ 15,000
Stock option granted		300,000
Common stock issued for services		32,000
Option exercise price		$ 1.00
Asset Purchase Agreement
Common stock issued						2,350,000
Asset Purchase Agreement | 2019 Incentive Plan
Common stock par value							$ 0.0001
Common stock issued							5,000,000

XML

Note 16 - Subsequent Event (Details)				1 Months Ended
	May 02, 2019	May 01, 2019 USD ($) shares	Apr. 09, 2019 a $ / shares shares	Apr. 30, 2019 $ / shares shares	Mar. 31, 2019 $ / shares shares	Feb. 14, 2019 $ / shares	Dec. 31, 2018 $ / shares shares
Common stock par value | $ / shares					$ 0.0001		$ 0.0001
Common stock issued					59,698,055		57,116,055
Share Price | $ / shares						$ 1.29
Subsequent Event [Member] | King
Lease term			10 years
Area of Land | a			50
Common stock issued during the period				1,000,000
Share Price | $ / shares				$ 0.50
Subsequent Event [Member] | Innovative
Working capital | $		$ 200,000
Subsequent Event [Member] | Consulting Agreement | Arthur Kwan
Common stock par value | $ / shares			$ 0.0001
Common stock issued			250,000
Stock option granted			250,000
Strike price | $ / shares			$ 0.65
Consideration description			Pursuant to the terms and subject to the conditions set forth in the Agreement, the Company shall, in consideration for licensing the Hydro Technology from Hydro, furnish to Hydro: (i) a one-time lump-sum cash payment of $60,000 (the “Cash Payment”) no later than July 3, 2019; (ii) four semiannual payments of $125,000 each for an aggregate of $500,000 in payments beginning on January 15, 2020 and culminating with a final payment on July 15, 2021, such $500,000 is convertible into shares of the Company’s common stock, par value $0.0001 per share at a conversion price of $1.00 per share or the market price at the time of conversion but not less than $0.75 per share; (iii) 2,125,000 shares of the Company’s Common Stock (the “Stock Payment”) and (iv) an annual license fee of $100,000 no later than January 15 of each year of the Term beginning in 2022.
Subsequent Event [Member] | Operating Agreement | Apothio
Subsequent Event, Description	Under the terms of the Operating Agreement, the Company will be required to: (i) underwrite costs to contribute extraction equipment; (ii) fund the cost of a fully-functional extraction facility and (iii) install a fully-functional testing laboratory with certain equipment as determined by the managers of the Joint Venture. Apothio will contribute existing biomass of approximately 150,000 pounds for the Company to begin processing and extraction, and will contribute some of its 512 acres of plants. The term of the Operating Agreement shall be perpetual absent certain dissolution provisions as further described in the Operating Agreement.
Subsequent Event [Member] | Operating Agreement | Mazza
Common stock issued		25,000
Subsequent Event [Member] | Operating Agreement | Gary and Gail Harstein Family Trust
Common stock issued		25,000